Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,16169,200,4.75 [2.05-10.97],0.0002670481903368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,15691,190,0.87 [0.66-1.15],0.3374307408805584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,18507,234,0.74 [0.60-0.92],0.0074647193795598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,15614,190,1.11 [0.75-1.65],0.6036029937458678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,18390,234,0.89 [0.72-1.10],0.2872354912546827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,18507,234,0.91 [0.76-1.09],0.3222623674841812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,16164,199,1.01 [0.92-1.11],0.779288171047865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,15614,190,0.94 [0.75-1.17],0.5659189840882795
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",18178,232,0.99 [0.85-1.15],0.9144974077629444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",15865,196,1.10 [0.91-1.32],0.3221901590967173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",16144,199,1.10 [0.94-1.28],0.2231718049785469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,18398,232,1.67 [1.09-2.58],0.0198048339315739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,16164,199,1.21 [0.75-1.98],0.4344952812443278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,18267,228,0.74 [0.58-0.94],0.014508427002613
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,15789,194,0.52 [0.34-0.80],0.0031551206750044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,16090,198,1.04 [0.92-1.17],0.5628683207568294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18596,234,1.00 [0.79-1.26],0.9764925470255228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,15656,189,0.79 [0.57-1.09],0.152159500394547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,18677,238,1.04 [0.73-1.47],0.8270310400337443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,18748,235,0.96 [0.82-1.14],0.6722844091393405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,16083,195,1.00 [0.72-1.41],0.9800952872679176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,15656,189,0.78 [0.67-0.90],0.0005922664573215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,15614,190,1.12 [0.77-1.63],0.5616179610977015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",18267,228,1.25 [0.99-1.59],0.0648903060661198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,15614,190,0.83 [0.65-1.06],0.1282385114844885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,18286,230,0.91 [0.62-1.32],0.6159542719177338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,18412,233,1.27 [0.82-1.96],0.2782995607853576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,18596,234,0.90 [0.74-1.10],0.3165822713248449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15614,190,1.09 [0.84-1.40],0.5146988927914065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,15741,194,0.89 [0.72-1.11],0.3113116634887399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,18819,237,0.88 [0.63-1.22],0.4277152352369047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,18512,231,1.07 [0.83-1.40],0.592141999833127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15656,189,1.57 [1.09-2.26],0.0151438838696151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18267,228,1.39 [0.95-2.03],0.0886210041851005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18447,234,1.22 [0.89-1.68],0.223257845446939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,18819,237,1.25 [0.89-1.76],0.2000995047517328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18732,236,1.02 [0.68-1.54],0.9254611823055592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,16090,198,1.24 [0.79-1.93],0.3520490246537634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15656,189,0.96 [0.61-1.51],0.8526799688607324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18829,238,1.09 [0.67-1.78],0.719379950839506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,18507,234,1.28 [0.96-1.70],0.0945308675856116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,18267,228,1.12 [0.82-1.53],0.4826928625533317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15656,189,1.22 [0.83-1.80],0.3009697027347244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18640,235,0.96 [0.74-1.24],0.7367712891707318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,16150,196,0.82 [0.54-1.23],0.3367534163433141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,15691,190,2.20 [1.25-3.88],0.0060623873670645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,16144,199,0.90 [0.64-1.28],0.5669959600799184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,18178,232,0.89 [0.60-1.34],0.5810371604054954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,15789,194,0.84 [0.69-1.03],0.0946250734192148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,18412,233,1.07 [0.76-1.52],0.6829767934958622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,15789,194,0.86 [0.60-1.23],0.4189294852996247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,16090,198,1.21 [0.95-1.55],0.1262450364082533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,18657,235,1.44 [0.97-2.14],0.0702871575839113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18738,237,1.18 [0.82-1.70],0.3630228767019692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,16144,199,0.76 [0.45-1.28],0.2995776369787446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,18507,234,0.95 [0.84-1.08],0.4621626246197369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,18596,234,1.88 [1.21-2.90],0.0045578491104416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,15653,191,0.88 [0.70-1.10],0.2513704254827603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,15789,194,0.82 [0.67-1.00],0.0499689494433206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,18267,228,0.99 [0.85-1.15],0.9162133549986192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,16169,200,1.09 [0.90-1.33],0.3761881873165756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,18771,235,1.23 [0.79-1.92],0.3637870029696435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,15614,190,1.13 [0.95-1.36],0.1686412834173466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,15789,194,1.11 [0.94-1.31],0.2267648443543919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFM,Afamin,16169,200,1.70 [0.88-3.31],0.1164947505186812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,18378,232,1.08 [0.90-1.29],0.4296686946227185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,15653,191,1.01 [0.87-1.18],0.8666034617562254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,18537,235,1.34 [1.02-1.76],0.0363212974513333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,18066,228,1.02 [0.90-1.15],0.8083566981284029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,18152,232,1.04 [0.85-1.27],0.7144380988155514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,18657,235,1.23 [0.89-1.70],0.2069833154539252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,18819,237,1.12 [0.89-1.40],0.3452430132595392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,16164,199,0.77 [0.40-1.51],0.448305835215287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,18596,234,0.95 [0.81-1.12],0.5381624421753469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,18596,234,0.90 [0.75-1.07],0.2428988731830224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15691,190,1.17 [0.75-1.83],0.4813432732608774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,15691,190,1.24 [0.81-1.88],0.3177061498846882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,16083,195,0.99 [0.80-1.22],0.9041122864903076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,16164,199,0.86 [0.52-1.43],0.566204224940112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,18560,236,0.83 [0.72-0.96],0.0096460527455019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",15730,191,0.93 [0.79-1.11],0.4359751758007105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,18178,232,0.94 [0.75-1.19],0.6291785445291189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,15691,190,0.81 [0.60-1.10],0.1759631663701358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18484,234,1.00 [0.89-1.11],0.9442406461436196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,18596,234,0.83 [0.69-1.01],0.0593456053387339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",16110,194,1.07 [0.94-1.22],0.3193736976377118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,15789,194,1.55 [0.83-2.88],0.1679749835857609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,18178,232,1.01 [0.86-1.19],0.8979624348010091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,15730,191,1.05 [0.84-1.30],0.6928915502473101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,18267,228,0.91 [0.70-1.16],0.4391773485600939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,15656,189,0.99 [0.80-1.22],0.9063464685704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,18200,231,0.92 [0.77-1.10],0.3516628556143031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,16120,197,1.01 [0.91-1.13],0.8520053720920574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,18091,231,1.00 [0.82-1.24],0.9665133353363128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18829,238,2.01 [1.14-3.54],0.0159171904334112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,18598,236,0.73 [0.58-0.93],0.0098171542319467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",16083,195,0.93 [0.69-1.25],0.6263929532015706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18561,236,0.91 [0.76-1.08],0.2768854119354431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",16120,197,0.91 [0.67-1.24],0.5645120689646872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,15865,196,0.88 [0.62-1.24],0.4557164030523355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,15656,189,1.00 [0.89-1.12],0.9776094567863708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",18507,234,0.96 [0.86-1.08],0.5199677558387704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,18286,230,0.95 [0.60-1.48],0.811360108953798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,18745,235,2.43 [1.41-4.20],0.0014147264070348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,16150,196,1.82 [1.05-3.14],0.0332412683209675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,18200,231,1.14 [0.96-1.36],0.1310311768287466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,15730,191,0.90 [0.67-1.22],0.5161482703669857
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,18507,234,1.33 [0.82-2.16],0.2513935203282911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,18286,230,1.03 [0.80-1.33],0.8113180920177341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,15789,194,1.37 [0.95-1.97],0.0872794168883791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,16016,194,0.90 [0.66-1.22],0.4814895877644308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,16110,194,0.78 [0.64-0.94],0.0113556004419519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,15139,190,0.93 [0.70-1.25],0.6364677145150162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,17919,225,1.09 [0.86-1.39],0.4881239439549595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,17360,219,1.10 [0.86-1.40],0.4561896178160268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,18570,232,1.36 [0.97-1.90],0.0746793298908019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,18520,234,0.94 [0.82-1.08],0.411595405471397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,18771,235,1.06 [0.79-1.43],0.6882019692447755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,18314,230,1.06 [0.70-1.61],0.7714984534334904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,18588,234,1.28 [0.96-1.73],0.0968622565908177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,18629,232,1.48 [1.06-2.08],0.0231326394620412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,18636,235,0.86 [0.66-1.12],0.2589780816386775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,18771,235,0.89 [0.65-1.24],0.5002011341949677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,15614,190,1.02 [0.83-1.24],0.8810013504980843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,15656,189,1.00 [0.83-1.19],0.9736759846654154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,15580,187,1.08 [0.84-1.39],0.5322289711213131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,18178,232,1.06 [0.87-1.29],0.5485857146044284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15691,190,1.15 [0.83-1.60],0.3922263825896236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,18661,235,1.23 [0.81-1.87],0.3376988736583231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,15710,194,0.96 [0.69-1.34],0.8061630234501285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,18200,231,1.04 [0.90-1.19],0.6171640268474075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,18554,235,0.98 [0.82-1.17],0.8194226336647086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,15466,188,0.88 [0.71-1.09],0.2378103371355759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,18732,236,1.01 [0.86-1.20],0.8966258062734587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,18517,234,1.01 [0.86-1.19],0.8713747306439596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,18137,231,1.15 [0.79-1.69],0.4598266476510195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],18286,230,0.97 [0.78-1.22],0.8126098605909828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,18686,235,1.13 [0.77-1.66],0.5265337910324879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,16083,195,0.97 [0.81-1.16],0.7311682581445489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,15730,191,1.04 [0.78-1.39],0.8007977643426587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,16090,198,0.99 [0.82-1.18],0.8734732690030726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,16110,194,1.03 [0.77-1.37],0.8433337370635495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18507,234,0.98 [0.76-1.27],0.8915174287722951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,16023,198,1.25 [0.82-1.92],0.3012915231872275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18719,234,0.99 [0.81-1.21],0.9449771869437305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,18596,234,1.06 [0.84-1.33],0.6387697759897788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,16169,200,0.78 [0.46-1.34],0.3726038985736961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,16164,199,1.07 [0.82-1.41],0.6127049171537722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,16169,200,1.37 [0.94-2.00],0.0988675836343409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,16164,199,1.31 [0.71-2.42],0.3863846490697142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,15691,190,1.03 [0.74-1.44],0.8747907491162805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,16144,200,0.92 [0.64-1.33],0.6710534008580687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,15453,193,0.69 [0.46-1.05],0.0814213127212646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,16169,200,1.02 [0.83-1.26],0.8244798651750868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,16164,199,0.97 [0.57-1.66],0.9213713284856192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,18598,236,1.28 [0.93-1.74],0.1267837903843871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,16164,199,1.00 [0.76-1.30],0.9741239865694028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,18663,234,1.62 [1.08-2.41],0.0186390627844221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,18574,236,0.96 [0.80-1.14],0.6137362947363492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,15789,194,1.03 [0.91-1.17],0.6107512183532262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,18417,234,0.94 [0.74-1.21],0.6430432865221767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,15865,196,1.01 [0.83-1.24],0.9099470731175092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,18507,234,0.95 [0.71-1.28],0.7562302736654588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,16090,198,1.03 [0.91-1.17],0.626764939404872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,16120,197,1.05 [0.86-1.28],0.6512162652300767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,18493,232,0.84 [0.67-1.06],0.1381032887565425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",16083,195,1.24 [0.93-1.66],0.1484907923394678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,18178,232,0.75 [0.58-0.97],0.0308353565237517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,18178,232,1.06 [0.88-1.29],0.5134822281515541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,15865,196,0.94 [0.66-1.34],0.7298946062656702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,15789,194,1.05 [0.89-1.25],0.5475872608203902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,15580,187,0.80 [0.65-0.99],0.0388036593954998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,16110,194,1.00 [0.86-1.17],0.9646944327022778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,16120,197,1.00 [0.87-1.16],0.9821855286916618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,18592,236,0.93 [0.83-1.04],0.1878396241044552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,15653,191,1.21 [1.02-1.44],0.0257279240079348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,15653,191,1.12 [0.80-1.57],0.4964106523528918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,18200,231,1.05 [0.79-1.40],0.7172928580569653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,15614,190,1.19 [0.98-1.44],0.0779356661095145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,15614,190,1.10 [0.77-1.56],0.5972881144854747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,15653,191,1.14 [0.93-1.41],0.2143433065498958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,18286,230,0.78 [0.54-1.11],0.1603813356851101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,15614,190,1.07 [0.83-1.38],0.6006808871475269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,18598,236,1.08 [0.83-1.39],0.5750673282690176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,18507,234,1.10 [0.89-1.36],0.367434712186415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,18686,235,0.98 [0.72-1.35],0.9248179728736906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,15653,191,1.04 [0.84-1.29],0.7074420614604799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,18286,230,1.09 [0.86-1.40],0.4689424417662522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,16007,194,1.34 [1.02-1.76],0.0368405335344107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,18447,234,1.03 [0.83-1.28],0.7804494413599277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,18447,234,1.33 [0.91-1.92],0.137855941526461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,16164,199,1.67 [1.03-2.70],0.0368210287183876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,16144,199,0.91 [0.55-1.51],0.7077376993389043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,16120,197,0.94 [0.76-1.16],0.5431944330488068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,15691,190,1.01 [0.87-1.16],0.928001541639424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,15614,190,0.83 [0.69-1.01],0.0566452946650849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,18200,231,1.06 [0.90-1.25],0.4809039262524122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,15580,187,0.87 [0.56-1.35],0.5326667900474844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,16090,198,0.98 [0.84-1.16],0.8430591600508685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,18178,232,0.76 [0.62-0.94],0.0106907057849614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,18640,235,0.99 [0.84-1.16],0.8723879867556907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15614,190,1.05 [0.78-1.40],0.7513244947731321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15614,190,1.36 [0.92-2.02],0.1261260961239947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,15614,190,0.87 [0.59-1.29],0.4888709878561039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,15580,187,0.84 [0.59-1.21],0.3539972797188728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,15614,190,0.96 [0.76-1.22],0.758922546615876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",15614,190,1.04 [0.80-1.36],0.7511663121349863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",18657,235,1.03 [0.92-1.14],0.6023937181162576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",18200,231,1.14 [0.90-1.46],0.2762708543490022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,18178,232,1.12 [0.84-1.48],0.4393936958701634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,18507,234,1.40 [0.97-2.00],0.0686208356242976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,18172,231,0.94 [0.79-1.13],0.5333740974269049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,15691,190,1.04 [0.86-1.27],0.6852800237248404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,15614,190,1.04 [0.90-1.20],0.6225598181582748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,16090,198,1.32 [0.91-1.93],0.1465933627880364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",16169,200,1.92 [0.84-4.38],0.1196447557443627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,18200,231,0.93 [0.79-1.09],0.3777372299623839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,15653,191,1.05 [0.92-1.19],0.4574982898240163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,16120,197,0.87 [0.64-1.18],0.3658775962996479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,16110,194,0.84 [0.67-1.05],0.1288915074035827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,18592,236,0.94 [0.83-1.06],0.2910831712511622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,18686,235,2.00 [1.32-3.02],0.0009821661779056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,16120,197,1.12 [0.88-1.42],0.3606086073817058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,18055,230,1.04 [0.89-1.21],0.6084936293420792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16169,200,1.29 [0.91-1.82],0.1543482182126245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,15614,190,1.42 [0.76-2.67],0.2703405639726963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15691,190,0.83 [0.57-1.21],0.3316119811848764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18657,235,1.58 [1.05-2.37],0.0285733927959405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",18598,236,1.50 [0.93-2.41],0.0947654090450847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,15656,189,0.73 [0.43-1.24],0.2484429061554167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,18592,236,0.90 [0.76-1.06],0.2159533915518561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,18412,233,1.24 [0.91-1.68],0.1704008891594068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,15656,189,0.93 [0.69-1.26],0.6547128604584367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,18267,228,0.78 [0.56-1.09],0.1531750727459619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,18178,232,0.99 [0.82-1.19],0.9214420503583926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,18178,232,1.77 [1.23-2.54],0.0021541468030137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,18592,236,0.92 [0.83-1.03],0.1560045423834916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,16110,194,1.02 [0.84-1.24],0.836725421240373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,15730,191,0.97 [0.82-1.15],0.7437335347287355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,18170,231,1.07 [0.94-1.22],0.3008311052271382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,18598,236,1.09 [0.68-1.76],0.7169436634930222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,18447,234,0.93 [0.67-1.30],0.6638285242102935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",16144,199,0.93 [0.59-1.46],0.7485497688744385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",15653,191,0.93 [0.70-1.22],0.5896263870968088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,15867,197,1.19 [0.70-2.00],0.5219172241130745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,16090,198,1.13 [0.90-1.43],0.2934642136381699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,16110,194,1.04 [0.90-1.20],0.5811263633650976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18592,236,0.86 [0.65-1.13],0.274195364959991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,15656,189,1.00 [0.78-1.28],0.9882378279718312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,15580,187,1.03 [0.83-1.28],0.797667263990202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,16083,195,1.07 [0.81-1.41],0.6322880500280803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,18592,236,0.95 [0.84-1.08],0.4268562622849534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,16150,196,1.01 [0.86-1.19],0.9058811081252552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,15691,190,0.92 [0.72-1.18],0.5214529698143108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,15580,187,0.78 [0.54-1.12],0.1712093554178347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,16150,196,1.07 [0.91-1.26],0.3933355916821439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,18152,232,1.05 [0.95-1.16],0.339848054188264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,15653,191,1.14 [0.95-1.36],0.1714425934109185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,15614,190,1.66 [0.99-2.80],0.0555050997626256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,18592,236,1.08 [0.92-1.29],0.3484700443813193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,18598,236,0.98 [0.86-1.11],0.7412891047540572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,18178,232,0.96 [0.79-1.16],0.6836216686962047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,18829,238,0.82 [0.56-1.21],0.3235063330697632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15656,189,1.29 [0.91-1.81],0.1485477273126809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,15653,191,1.02 [0.84-1.23],0.8424792890320025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,16110,194,1.08 [0.77-1.51],0.6625890800255834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,18598,236,0.81 [0.67-0.97],0.0203220398690609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,15789,194,1.68 [1.04-2.71],0.0344719211326937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,18412,233,0.81 [0.62-1.05],0.1085749869084057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,18237,228,0.82 [0.61-1.11],0.2088749460342507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,15789,194,1.53 [0.88-2.66],0.1317373959388602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,16144,199,1.35 [0.93-1.96],0.1115966962421026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15656,189,0.86 [0.61-1.22],0.4035609623852542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,18267,228,1.33 [0.80-2.22],0.2734741122725015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,15653,191,1.03 [0.79-1.33],0.8353665547322302
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,15691,190,0.83 [0.63-1.08],0.1633337758537237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,15145,184,0.93 [0.81-1.07],0.3000374260190966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,18567,232,1.02 [0.85-1.22],0.831035317263865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,16115,198,1.21 [0.98-1.48],0.0757447188994406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,15927,197,1.00 [0.88-1.14],0.9900827104174552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,15865,196,1.18 [0.76-1.84],0.4659322641640699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,15653,191,1.15 [0.80-1.66],0.4577462967686201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,15614,190,0.95 [0.70-1.28],0.7149200877728449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,15614,190,1.02 [0.70-1.49],0.9016705724821822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,18200,231,1.31 [1.02-1.69],0.0364316902444805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,15653,191,1.37 [1.04-1.80],0.0263947381651478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,16120,197,1.43 [1.01-2.02],0.0429332643019125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSG,Basigin,18786,237,0.88 [0.51-1.53],0.6518336872213462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSND,Barttin,15580,187,0.76 [0.48-1.22],0.2613772088429883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18763,237,1.17 [0.89-1.54],0.2700995389113113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,18763,237,1.01 [0.79-1.28],0.9563311589406251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,18178,232,0.93 [0.79-1.10],0.4176937316430292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,16169,200,1.06 [0.54-2.07],0.8671658359072942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,15580,187,0.98 [0.83-1.16],0.8100241326874741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,16050,195,1.25 [0.92-1.69],0.1558691721792748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18657,235,1.48 [0.98-2.24],0.0618618267688923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,18592,236,1.03 [0.75-1.40],0.8688811540322403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,15580,187,0.98 [0.70-1.39],0.9245243843714924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,18200,231,0.95 [0.79-1.14],0.5724531730011757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,15614,190,1.03 [0.67-1.59],0.8908462124171075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,18727,236,0.81 [0.48-1.37],0.4406477579688794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",16120,197,0.94 [0.75-1.16],0.5439542042794154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,15656,189,0.92 [0.65-1.29],0.6212769777615208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18686,235,1.09 [0.83-1.42],0.545228205603039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15789,194,0.84 [0.58-1.23],0.3791441687652178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,16120,197,1.36 [0.94-1.95],0.0991767837276164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,15764,193,0.98 [0.74-1.30],0.8757348721705758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,16169,200,1.73 [0.89-3.38],0.1083867963800027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,16134,200,3.18 [1.55-6.53],0.0016172182509597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,16169,200,2.73 [1.53-4.86],0.0006726170774279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2,Complement C2,18663,234,3.10 [1.70-5.67],0.0002385449773783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,18172,231,1.36 [1.07-1.73],0.0132715487689255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,15730,191,0.97 [0.76-1.25],0.8346337378181657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C3,Complement C3,15347,187,1.07 [0.78-1.45],0.6866362456035251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,18640,235,1.59 [1.19-2.14],0.0017930778800645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C5,Complement C5,16169,200,1.95 [0.79-4.85],0.1488149529186116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,15783,193,0.87 [0.57-1.33],0.5136948157562976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,16110,194,1.20 [0.72-2.01],0.4803302437713559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,16169,200,1.17 [0.75-1.84],0.4839961824249172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,16164,199,0.98 [0.77-1.24],0.8389525355709262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,16090,198,0.83 [0.69-0.98],0.0293313209544888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,18232,229,0.72 [0.59-0.89],0.0020767888690477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,18178,232,1.04 [0.71-1.53],0.8277636612437771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,18507,234,1.39 [0.99-1.95],0.0546166447593782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,18371,231,0.99 [0.88-1.11],0.8560845897595457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,18771,235,0.81 [0.59-1.12],0.2079938208333165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,18540,236,0.78 [0.66-0.93],0.0058458398380631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,18804,238,0.75 [0.61-0.92],0.0056530392056348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,18829,238,0.98 [0.62-1.56],0.9481879764014276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",18267,228,0.95 [0.83-1.09],0.4476629509682748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,18539,235,0.78 [0.65-0.94],0.0090863900153534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,15865,196,0.95 [0.62-1.44],0.8036959841965958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,15656,189,0.89 [0.49-1.61],0.7002408319994515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,18771,235,1.05 [0.83-1.32],0.7020782670407762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,15730,191,1.10 [0.89-1.35],0.3769604205936446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,15653,191,0.87 [0.55-1.38],0.5433346231550602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,15614,190,1.00 [0.78-1.29],0.9782142960291776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,15653,191,1.14 [0.92-1.41],0.2459327875843978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,16120,197,1.03 [0.87-1.21],0.757033879572523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,15762,194,1.06 [0.92-1.22],0.4152655653200698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,15730,191,1.41 [1.07-1.86],0.0156596327997014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,18507,234,1.14 [0.89-1.47],0.3072812806308227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,18200,231,1.30 [0.88-1.90],0.185601801602789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,18419,234,0.90 [0.75-1.07],0.2310854259245538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,16110,194,1.01 [0.71-1.41],0.9752759459802832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,18717,235,0.93 [0.83-1.04],0.2006568201637011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15691,190,1.01 [0.84-1.23],0.8926725369780936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,15614,190,1.13 [0.80-1.58],0.4903825987451186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,18178,232,1.02 [0.78-1.34],0.872457181456778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15730,191,1.07 [0.82-1.38],0.6157417340725788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,16120,197,0.97 [0.85-1.11],0.6942062440991765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18532,233,1.78 [1.00-3.16],0.0498718893806838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,18481,231,1.09 [0.90-1.33],0.3778712677547323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,16083,195,1.12 [0.78-1.62],0.540574710389462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,16110,194,1.02 [0.89-1.16],0.7688346663067755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,18200,231,0.69 [0.54-0.88],0.003188909792356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,15730,191,1.08 [0.78-1.51],0.6342057082792997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,18200,231,1.20 [1.03-1.39],0.0199586874191634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,18200,231,1.00 [0.85-1.19],0.9572616787111292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,18592,236,0.91 [0.77-1.09],0.2987423867035548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,18829,238,0.96 [0.84-1.09],0.4979761168550355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,15865,196,0.95 [0.86-1.03],0.2226880809282323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,16110,194,1.08 [0.91-1.27],0.3814854585428855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,18722,235,0.92 [0.76-1.12],0.4026277145774973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,15656,189,0.91 [0.71-1.15],0.4154056022488644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,15614,190,1.02 [0.77-1.36],0.886053599729516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAT,Catalase,15931,198,0.73 [0.56-0.96],0.0235500506047783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,18575,233,1.04 [0.90-1.20],0.6273279309721553
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,15653,191,1.06 [0.92-1.22],0.3918332795373572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,18771,235,1.35 [0.98-1.85],0.0638690945829722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,15691,190,1.07 [0.81-1.40],0.6352118780473445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,15614,190,0.95 [0.65-1.38],0.7840179719871619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,18447,234,0.88 [0.74-1.04],0.1197563843737598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,16110,194,1.18 [0.97-1.45],0.1057959585249533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,16083,195,1.11 [0.84-1.48],0.4572900639979024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,15730,191,1.10 [0.68-1.77],0.699556759622455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,16120,197,0.87 [0.71-1.07],0.1803029031044936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,18596,234,1.01 [0.74-1.39],0.9500245971432842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,15691,190,1.09 [0.87-1.36],0.4376784404454368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,18819,237,1.10 [0.81-1.50],0.549354068941012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,18792,237,0.87 [0.74-1.04],0.1228084379917856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,18570,232,1.58 [1.23-2.03],0.0002928449192236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,18829,238,1.15 [0.89-1.48],0.2871082370066907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,18829,238,1.08 [0.86-1.35],0.504671623131392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,18539,235,1.09 [0.96-1.23],0.1792767261514507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,18367,228,1.14 [0.98-1.33],0.0930953750691651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,18763,237,1.02 [0.93-1.12],0.6912047986709271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,18412,233,0.95 [0.76-1.19],0.6596695788895099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,18819,237,1.09 [0.97-1.24],0.1587436118046074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,18657,235,1.12 [0.84-1.51],0.4335087040859072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,18380,235,1.29 [1.04-1.60],0.0193471599555252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,18657,235,1.30 [0.98-1.71],0.0665135372771271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,18636,235,1.03 [0.90-1.19],0.6505054940235575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,18819,237,1.13 [0.89-1.43],0.307148499578838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,18592,236,1.05 [0.93-1.18],0.4107740688523501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,18596,234,0.95 [0.78-1.15],0.587074331737507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,18529,236,1.18 [0.98-1.43],0.0761036602685065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18592,236,1.17 [0.99-1.39],0.0722451260434711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,18599,235,0.92 [0.75-1.12],0.3832643612670934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,18686,235,1.08 [0.96-1.20],0.2078118949624304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,18592,236,1.08 [0.89-1.31],0.4469892876695024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,18745,235,0.99 [0.82-1.20],0.9187440603849658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,18481,234,1.02 [0.87-1.20],0.825057715773536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,18582,234,0.87 [0.71-1.08],0.2204502225371637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,18792,238,1.92 [1.42-2.61],2.270772999756979e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,18771,235,1.18 [0.87-1.58],0.284107345944665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,18598,236,0.79 [0.58-1.08],0.139070646305003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,15865,196,1.11 [0.76-1.64],0.5887710872734293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,15656,189,0.90 [0.74-1.08],0.2627906339936185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,18447,234,0.84 [0.65-1.08],0.1652281096097103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,18178,232,0.85 [0.65-1.12],0.2562427319958831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,16090,198,0.99 [0.72-1.34],0.9241058625772366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,18598,236,0.97 [0.69-1.38],0.8857126999411018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18257,230,1.57 [1.19-2.06],0.0014759964391154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,18819,237,1.27 [1.01-1.61],0.0419582905127962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18686,235,1.32 [1.01-1.71],0.0398194496915263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,18598,236,1.35 [0.94-1.92],0.1003521491144664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,15730,191,1.05 [0.72-1.53],0.8106150025670981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,18566,236,1.03 [0.94-1.13],0.5120075080890836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,18640,235,2.00 [1.24-3.24],0.0046890159024871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,15614,190,0.99 [0.70-1.41],0.9612569548110018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18592,236,1.06 [0.68-1.64],0.79955115214445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,18526,236,1.48 [1.08-2.02],0.0155515841032713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,18164,230,1.20 [0.89-1.62],0.2317707979342868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,18644,234,0.87 [0.64-1.18],0.3667798135621989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18819,237,1.23 [0.94-1.60],0.1321771629582558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,15656,189,1.33 [0.95-1.86],0.0917140217320471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,18819,237,1.47 [0.98-2.19],0.0623371150159988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,16150,196,0.87 [0.62-1.23],0.4380712683619627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18640,235,1.15 [0.87-1.51],0.3301279943502684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,18447,234,1.19 [0.85-1.66],0.3151463601439376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,18567,235,1.13 [0.82-1.56],0.4545837033343315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18178,232,1.35 [1.00-1.82],0.0480532412630062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,18596,234,0.89 [0.73-1.07],0.2076482802849449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,15789,194,1.25 [0.80-1.95],0.3254946168176728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,18763,237,1.24 [0.90-1.71],0.1983416173511311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,18716,234,1.33 [1.02-1.74],0.0353913148850574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,18771,235,1.33 [1.08-1.63],0.0077697198987855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,18598,236,1.11 [0.82-1.50],0.5118788066381266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,18507,234,1.35 [0.95-1.93],0.0988630601311142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,18640,235,1.13 [0.97-1.32],0.1106544846365505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,18703,237,1.45 [0.90-2.33],0.1249775483661345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,15656,189,1.14 [0.84-1.55],0.3984015764191334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18507,234,0.81 [0.57-1.16],0.2547364293548313
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,15653,191,0.88 [0.57-1.37],0.5746472026974404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,15865,196,0.88 [0.58-1.36],0.5725704713263002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,15656,189,1.02 [0.87-1.19],0.8356940872398199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,18560,236,0.92 [0.62-1.37],0.6684725458150268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,18578,235,1.08 [0.85-1.36],0.5368286305660686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,18819,237,0.97 [0.84-1.12],0.6431072334150381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,18516,232,1.45 [0.98-2.14],0.059836351892298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18636,235,1.40 [0.95-2.05],0.0853125188968635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18745,235,1.13 [0.80-1.59],0.4814350922829699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,17975,230,1.19 [0.77-1.82],0.4373369860117024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,18533,235,1.48 [0.76-2.87],0.2439378110802346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,17956,231,1.04 [0.63-1.71],0.8853383494163051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,16101,200,1.09 [0.82-1.45],0.5593893927993092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18786,237,0.99 [0.79-1.25],0.9615612813770158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,18412,233,1.04 [0.82-1.31],0.7643351404285454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,18504,234,1.00 [0.88-1.14],0.9815223759022658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,15628,188,1.03 [0.75-1.43],0.839437447026011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18592,236,0.88 [0.67-1.15],0.3489036345091419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15789,194,1.27 [0.92-1.76],0.1479240289219974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18763,237,1.13 [0.81-1.59],0.4729530518621437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18819,237,1.23 [0.96-1.59],0.1046402278730188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16144,199,1.53 [1.04-2.25],0.0317435390481038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,15865,196,1.17 [0.86-1.59],0.3077101631079965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18592,236,1.30 [0.93-1.82],0.1228393964750138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,18592,236,0.85 [0.59-1.22],0.3673233162222667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,16090,198,1.75 [1.12-2.75],0.013980909774503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18763,237,1.30 [1.05-1.60],0.0172660640912504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,17919,224,1.53 [1.06-2.21],0.0231863994618193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,18598,236,1.32 [0.74-2.36],0.3463346487484973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,18598,236,1.17 [0.73-1.88],0.5008790994070915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,16123,199,1.20 [0.91-1.58],0.2022491133267279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,16110,194,1.12 [0.61-2.04],0.714316051776819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,15580,187,0.87 [0.67-1.12],0.2780627382057583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,15580,187,0.88 [0.60-1.30],0.5289155439976182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,16052,198,0.96 [0.78-1.17],0.6773778072523677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,18178,232,1.01 [0.83-1.23],0.9087413719510792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,18640,235,0.96 [0.84-1.11],0.6164880755202367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,16090,198,0.97 [0.85-1.11],0.670280725781015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,18447,234,1.19 [0.98-1.45],0.0813930983058199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,17997,229,1.45 [1.13-1.86],0.0033625870352214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,18735,237,0.92 [0.78-1.08],0.3024278232897911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,18596,234,1.15 [0.98-1.35],0.0917239157470196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,18596,234,1.12 [0.81-1.56],0.4930107553826472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,15865,196,0.69 [0.40-1.18],0.1724994746615852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,16110,194,1.23 [0.74-2.05],0.4294725193797394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18763,237,1.25 [0.92-1.70],0.1577864009302996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,15653,191,0.88 [0.64-1.21],0.4326647113980789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,18829,238,1.30 [0.89-1.89],0.1782024594622842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,18596,234,1.22 [0.91-1.64],0.1848743674820376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,18200,231,1.08 [0.83-1.42],0.5632735109868656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,18507,234,0.93 [0.77-1.11],0.4051824918833534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,18596,234,1.41 [1.03-1.93],0.0305073585547745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,15580,187,0.74 [0.50-1.08],0.1198315324077376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,16120,197,0.99 [0.78-1.25],0.9459790843324226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,15653,191,1.08 [0.83-1.41],0.5540863695286591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,18507,234,0.93 [0.84-1.04],0.2287901613195427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,18507,234,0.99 [0.87-1.12],0.8165671513639925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,18507,234,1.02 [0.72-1.46],0.9015912181271498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18597,235,1.02 [0.65-1.61],0.9348051467308808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,18768,237,0.92 [0.71-1.20],0.5302688503127535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18611,233,0.70 [0.42-1.16],0.1633856140088417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,16090,198,1.17 [0.98-1.38],0.0804264622645086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,15865,196,1.11 [0.93-1.32],0.2577536011058493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16090,198,0.70 [0.50-0.99],0.0411789440239541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15865,196,1.03 [0.75-1.41],0.8594662495397781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18592,236,0.91 [0.79-1.04],0.1638973047711402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,18178,232,0.96 [0.75-1.25],0.7810244278346743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17942,231,1.13 [0.94-1.36],0.1881148990200509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16150,196,0.92 [0.66-1.29],0.6316997188041464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18267,228,1.11 [0.88-1.41],0.3820945917061069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,15656,189,0.94 [0.62-1.44],0.7838056793525834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,18267,228,1.15 [0.85-1.56],0.3598012287185173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,16150,196,1.07 [0.86-1.33],0.5365011183636155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,18797,237,1.12 [0.93-1.35],0.2344819620443667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,15789,194,1.12 [0.70-1.80],0.6262936832654429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,15656,189,1.27 [0.83-1.94],0.2658867701195836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,15653,191,1.13 [0.92-1.39],0.2448728388217537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,15865,196,0.91 [0.70-1.17],0.4531127480811765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,15865,196,0.91 [0.74-1.13],0.3906547063515717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,15614,190,0.99 [0.73-1.35],0.9496864537731876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,15580,187,0.90 [0.63-1.28],0.5527911213797433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,18286,230,1.01 [0.83-1.23],0.9127239841170824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,15691,190,1.06 [0.88-1.27],0.5611705533093009
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,18178,232,1.11 [0.95-1.29],0.2000224947260355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,15865,196,0.90 [0.68-1.18],0.4335171386976295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,15580,187,1.27 [0.89-1.81],0.1881159419430192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,18123,224,1.01 [0.84-1.20],0.94097457981945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,18178,232,0.99 [0.83-1.20],0.946554421235044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,18200,231,1.07 [0.88-1.29],0.5233781858390489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,18642,236,0.99 [0.86-1.14],0.8835377765171961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,18507,234,0.91 [0.74-1.13],0.4113288882112035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,18507,234,0.86 [0.72-1.03],0.1000905429322494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,18200,231,1.03 [0.86-1.22],0.7470535659629025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,16090,198,1.01 [0.84-1.21],0.9149957004798422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,15893,194,1.58 [1.03-2.42],0.0365822913315454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,18178,232,1.01 [0.79-1.30],0.9200258348290072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,16169,200,0.84 [0.44-1.62],0.608734404129182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,15251,180,2.01 [1.08-3.72],0.0265397822671447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,16054,199,1.28 [0.99-1.67],0.0613736626108241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,16134,199,1.29 [1.05-1.58],0.0139944059876871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,15964,197,1.15 [0.82-1.61],0.423166981741685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,16169,200,3.13 [1.56-6.30],0.0013466102474356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFP,Properdin,16169,200,2.00 [1.32-3.05],0.0012083352148849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18598,236,1.41 [1.20-1.66],2.753266247532762e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,16164,199,1.11 [0.76-1.61],0.5959399199367852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,15730,191,1.43 [1.05-1.94],0.0229150833051565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,18596,234,1.15 [0.88-1.50],0.3104162269726237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,18178,232,0.80 [0.64-0.99],0.0378117075160228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,15789,194,1.15 [0.86-1.54],0.3534958819069526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16110,194,1.16 [0.85-1.58],0.3616259494946408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,16083,195,1.39 [0.90-2.14],0.1389877089625119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,18267,228,1.00 [0.69-1.44],0.9944077720168126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,16150,196,1.16 [1.02-1.32],0.0292410191531117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,18713,237,1.25 [0.95-1.63],0.1062271278869677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,18220,231,1.00 [0.87-1.15],0.9508838604504084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,18685,236,1.02 [0.94-1.09],0.6611675082827635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,18656,232,1.44 [0.99-2.10],0.0564361489931804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,15730,191,0.95 [0.75-1.20],0.6544037115716734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,18447,234,1.06 [0.91-1.23],0.4424139425741812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,16144,199,1.12 [0.88-1.43],0.3484118111746335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,15653,191,1.07 [0.89-1.28],0.4872867348160372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,18636,235,1.17 [0.82-1.66],0.3812477167409694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,18596,234,0.75 [0.58-0.96],0.0245865074704817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,15730,191,1.26 [0.88-1.78],0.2020094378959555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,18640,235,0.93 [0.76-1.12],0.4274742424955763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,16150,196,1.00 [0.78-1.28],0.9867836182227648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,15865,196,0.99 [0.72-1.36],0.9413962150796432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,16090,198,1.07 [0.92-1.23],0.3908589857987562
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,15730,191,0.98 [0.73-1.32],0.9128982821366164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18728,237,1.21 [0.83-1.77],0.3149602240182801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,16150,196,0.79 [0.62-1.01],0.0566599187707799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18514,235,0.97 [0.81-1.16],0.717792642406002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,15580,187,0.85 [0.68-1.04],0.1184330587707817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,18566,233,1.04 [0.88-1.24],0.6237408240356586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,18447,234,1.08 [0.78-1.50],0.6400922370699006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,18570,236,1.04 [0.82-1.33],0.7392303890176791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15656,189,1.61 [0.82-3.16],0.1652598290676926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,18598,236,1.22 [0.86-1.72],0.2604421725097626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,18267,228,1.38 [0.99-1.93],0.0577776429886374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,18763,237,1.03 [0.92-1.17],0.5811346765381712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,15730,191,1.14 [0.90-1.45],0.2771080271657711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,15804,193,1.14 [0.60-2.15],0.6852464409617391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,18592,236,0.91 [0.66-1.27],0.5911379377085614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,18592,236,1.18 [0.92-1.49],0.1886593801548916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,18592,236,0.98 [0.81-1.19],0.8492585130389265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,18592,236,1.51 [1.07-2.13],0.0202982372846181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,16127,195,0.86 [0.65-1.15],0.3028487935362081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,18536,234,1.30 [0.90-1.90],0.1626206910446165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,18178,232,1.15 [0.89-1.47],0.2842737916359372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,18819,237,1.01 [0.84-1.22],0.9102419845518596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,15730,191,1.61 [1.26-2.07],0.0001489205326114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,15730,191,0.96 [0.61-1.51],0.8532977111076211
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,15580,187,0.87 [0.62-1.22],0.4285746394897476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,18592,236,0.99 [0.89-1.10],0.852519397776815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,18771,235,1.84 [1.12-3.02],0.0156416237686703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,15730,191,0.48 [0.30-0.76],0.0015522154994394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18419,234,1.04 [0.92-1.18],0.520285194287554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,18560,236,1.12 [0.96-1.31],0.1485155471267815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,18172,231,0.90 [0.64-1.28],0.5643215904250638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,18200,231,1.10 [0.88-1.36],0.4054670434225851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,18819,237,0.72 [0.53-0.98],0.0385842737976832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,16110,194,1.37 [0.89-2.11],0.1569441671631763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,18267,228,0.95 [0.73-1.24],0.7306104961031066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,16169,200,1.09 [0.67-1.77],0.7157642876385996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,18562,234,1.05 [0.80-1.37],0.7285773273373953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,16144,199,1.08 [0.93-1.26],0.3043995873885863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,16083,195,0.97 [0.82-1.14],0.6863692559965536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,18686,235,1.48 [1.13-1.95],0.0043258560921075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,15653,191,1.30 [1.06-1.58],0.0102771356103689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",15662,189,0.95 [0.79-1.14],0.5623710743055161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,18267,228,1.08 [0.90-1.30],0.3792799834803158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,18507,234,0.96 [0.82-1.12],0.6251558789749725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNST,Consortin,18596,234,1.01 [0.90-1.12],0.9087948712802484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,15653,191,1.21 [0.81-1.82],0.3492558251236906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,18829,238,0.83 [0.55-1.26],0.3878859504787649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,18771,235,0.92 [0.71-1.19],0.5263435482370309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,18598,236,1.05 [0.69-1.60],0.8102804026307782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,18598,236,1.43 [0.88-2.32],0.1514405726305343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,18647,236,1.08 [0.78-1.48],0.6535923475299841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,18592,236,0.90 [0.68-1.19],0.4726110036600267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,15730,191,1.04 [0.92-1.18],0.5388329660894785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,16144,199,1.03 [0.77-1.38],0.8381835453424382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,16150,196,0.93 [0.56-1.54],0.7893996116885552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,18673,237,1.47 [0.92-2.37],0.1097302522441706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,18829,238,1.82 [1.14-2.89],0.0119707074084757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,16090,198,1.24 [0.97-1.59],0.0803019241132712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,15730,191,1.02 [0.86-1.22],0.807098482973958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,15691,190,0.93 [0.77-1.12],0.4329931644182612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,16150,196,1.43 [0.79-2.58],0.2365319717036635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,18596,234,0.85 [0.63-1.15],0.2976320766846222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,15836,196,1.08 [0.83-1.41],0.5781232357752829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,15789,194,1.18 [0.85-1.66],0.3249450313221973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,18829,238,1.38 [1.03-1.85],0.0327125985611706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,18592,236,1.14 [0.89-1.45],0.3154604580932039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,15865,196,0.52 [0.35-0.77],0.0012506151542479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,18567,235,1.56 [1.04-2.34],0.031943995263028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,15691,190,1.00 [0.79-1.27],0.993807234257136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,16083,195,0.80 [0.55-1.17],0.2458742372132801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,18421,230,1.12 [0.79-1.60],0.5144610787357193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,18066,224,0.89 [0.76-1.03],0.1151503641480978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',15614,190,0.81 [0.58-1.13],0.215134430293146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,18200,231,0.90 [0.69-1.18],0.4509986982039347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15691,190,1.20 [0.88-1.62],0.2440843120014367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,18227,227,1.00 [0.88-1.15],0.9428035911800128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,15653,191,1.11 [0.77-1.61],0.5715055713535002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18507,234,1.02 [0.86-1.21],0.7805913882206428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,16144,199,1.28 [0.85-1.92],0.239859486338274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,18829,238,1.02 [0.86-1.22],0.7933226716862055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,18708,235,1.15 [0.98-1.36],0.095453099786018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,15482,187,1.04 [0.75-1.45],0.8176963966152221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,18829,238,1.06 [0.89-1.27],0.5242340272948893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,16144,200,2.85 [1.56-5.20],0.0006214197113382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,18608,232,0.93 [0.70-1.24],0.624857698869655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,15580,187,1.05 [0.68-1.62],0.8383014219736173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,18677,237,1.05 [0.75-1.47],0.7822687295807401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",15656,189,1.01 [0.61-1.67],0.9788510837592004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,18763,237,0.91 [0.76-1.09],0.3114113901485558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,16123,196,1.21 [0.82-1.80],0.3330947647798318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,15614,190,0.84 [0.57-1.23],0.3750717251430159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,18736,235,1.22 [0.91-1.63],0.1825251016927617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,18640,235,1.00 [0.84-1.18],0.9932281758725404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,16144,199,1.85 [1.12-3.06],0.016748174001025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,16108,199,1.42 [0.97-2.08],0.0682503718379103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18686,235,1.25 [0.98-1.59],0.076767134222678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,18178,232,1.00 [0.87-1.15],0.9948019526306188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,18419,234,0.94 [0.80-1.10],0.4135916411985745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,15580,187,0.92 [0.70-1.21],0.5456344182112505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,15580,187,1.16 [0.67-1.98],0.5995047831122016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,18352,232,0.90 [0.67-1.20],0.4695697603123455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,15789,194,0.93 [0.63-1.36],0.6927865810323088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,18636,235,1.15 [0.92-1.44],0.2091544731302206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,18150,230,0.93 [0.80-1.07],0.2867439186980117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,18567,235,2.11 [1.38-3.23],0.0006172461484172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,18267,228,1.15 [0.96-1.37],0.1351753780710836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,18657,235,1.17 [0.67-2.03],0.5873894901027727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,18447,234,1.00 [0.73-1.36],0.993349835959874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,18771,235,0.97 [0.78-1.20],0.7725861360870372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,16008,197,0.84 [0.51-1.40],0.512613536465764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,18602,235,0.96 [0.86-1.07],0.4486772493265583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,18657,235,1.54 [0.97-2.46],0.0694076317892531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,18070,228,1.22 [1.03-1.45],0.0197224459850322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,18829,238,1.19 [0.81-1.73],0.37030283172964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18447,234,1.03 [0.82-1.30],0.7789678216662816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,15730,191,1.03 [0.78-1.35],0.8436403812597918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,18267,228,0.98 [0.88-1.10],0.7841610367853908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,16144,199,1.04 [0.84-1.29],0.7306298575172963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,16110,194,0.88 [0.72-1.08],0.2368696979065505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,16110,194,0.93 [0.81-1.08],0.3522431245569828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,15653,191,0.96 [0.79-1.18],0.7179341581747847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,15691,190,0.97 [0.82-1.14],0.6947209517871855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,15614,190,0.99 [0.88-1.11],0.8572549737355386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18657,235,1.82 [1.20-2.74],0.0044648263865536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,16164,199,1.29 [0.94-1.78],0.1155430807941034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,15614,190,1.09 [0.74-1.59],0.6720159185824974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18447,234,1.03 [0.85-1.25],0.7459385661062814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,15656,189,1.14 [0.81-1.59],0.4601433100530585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,18286,230,1.18 [0.93-1.49],0.1786086010984594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,15656,189,0.95 [0.58-1.55],0.8286766661213791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,16164,199,0.98 [0.61-1.58],0.9246192643549764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,15656,189,1.04 [0.83-1.31],0.7098206043895368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,16120,197,0.86 [0.63-1.18],0.3511689087516992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,16150,196,0.98 [0.65-1.47],0.9166915699080076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,15653,191,0.99 [0.75-1.32],0.9661818543125186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,15614,190,0.83 [0.71-0.98],0.0237845411159612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,14020,171,1.01 [0.88-1.17],0.8470508396864865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,18651,235,1.44 [0.99-2.10],0.0564531433915023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,18215,232,1.04 [0.85-1.28],0.6970391200825001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,18121,232,0.67 [0.53-0.85],0.00082466140328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,18599,235,1.12 [1.01-1.25],0.0355641366079072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,18346,234,0.92 [0.70-1.21],0.5440541724364576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,15838,196,1.12 [0.85-1.48],0.4118482911909042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,15942,198,1.07 [0.63-1.82],0.7980751579303178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,18267,228,0.97 [0.84-1.12],0.6767926962747777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,16150,196,1.06 [0.66-1.70],0.8082817514443039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,16150,196,1.16 [0.78-1.73],0.4640034911164404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,15653,191,0.92 [0.58-1.44],0.7042288855093639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,18598,236,1.00 [0.82-1.21],0.975058046046632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,18567,235,1.06 [0.89-1.26],0.5144362524996842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,16110,194,1.08 [0.89-1.31],0.4224132222030565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,18605,237,0.85 [0.68-1.06],0.1483665329779938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,18532,234,0.90 [0.69-1.17],0.4401797403564469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,17410,225,0.95 [0.71-1.28],0.7565467288677566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,15789,194,1.03 [0.79-1.34],0.8514798352115955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,18640,235,1.16 [0.86-1.55],0.3355301534408121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,18205,228,1.23 [1.05-1.44],0.0091426886770126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18596,234,1.49 [0.94-2.36],0.0918843462316204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,18819,237,1.00 [0.69-1.47],0.9836515576859528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,14677,184,1.20 [0.66-2.19],0.5553114938797881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18701,234,0.73 [0.55-0.99],0.0417293370837666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,18627,234,1.10 [0.77-1.59],0.5977353337326042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,15730,191,0.87 [0.60-1.28],0.4905569694786045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,15999,198,0.96 [0.76-1.21],0.7380279693340316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,18447,234,1.20 [0.85-1.70],0.3054362864885516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,18592,236,1.07 [0.84-1.37],0.576192345497576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,18547,235,0.96 [0.85-1.09],0.5313017996984427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,18657,235,1.10 [0.93-1.31],0.2755723059623091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,18763,237,1.04 [0.90-1.20],0.600228960314551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,18286,230,0.71 [0.53-0.97],0.0297175581077922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,18763,237,1.00 [0.82-1.21],0.9731196187199822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,18286,230,0.89 [0.71-1.12],0.333372705465946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,18798,238,1.12 [0.68-1.83],0.6541480469465222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,18819,237,1.30 [1.00-1.69],0.0465513094113774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,18578,235,0.99 [0.87-1.12],0.838866386939841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,18534,234,1.03 [0.93-1.15],0.5256782118384027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,18819,237,0.98 [0.84-1.14],0.7952044717401328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,18486,230,1.08 [0.92-1.28],0.3431284515460705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18657,235,1.07 [0.89-1.28],0.4652655158215452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,15580,187,1.14 [0.96-1.37],0.1381206333296094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15925,197,1.11 [0.87-1.42],0.3985067032442188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15614,190,0.98 [0.83-1.16],0.8280823863112592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,15580,187,0.90 [0.73-1.12],0.3531493859909376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,16150,196,0.80 [0.46-1.37],0.4108205157319932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,15789,194,1.07 [0.91-1.27],0.4157947988585925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,18771,235,1.00 [0.90-1.11],0.9528091023215118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,18657,235,0.98 [0.76-1.26],0.8764252481292332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,15656,189,0.98 [0.76-1.26],0.8488808976308848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,15656,189,1.09 [0.86-1.39],0.4752120414340482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,18592,236,0.98 [0.89-1.08],0.7053448784955161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",18419,234,0.86 [0.73-1.01],0.0743697675654649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,16143,199,0.95 [0.84-1.06],0.3470951076627128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,18511,236,1.01 [0.86-1.18],0.9179693922603708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,15656,189,1.04 [0.78-1.38],0.7944683029828463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,18657,235,0.96 [0.85-1.10],0.5803946443094916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18640,235,0.99 [0.71-1.37],0.9434080997237364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,15730,191,1.03 [0.55-1.91],0.9338756168848508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,15580,187,0.97 [0.76-1.22],0.7656158189255768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,15580,187,0.64 [0.40-1.04],0.0692376014074732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCN,Decorin,18267,228,1.15 [0.70-1.88],0.5883239682541697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,15789,194,1.04 [0.90-1.21],0.5692465597845295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,18771,235,0.94 [0.79-1.14],0.5470110212209185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,18507,234,0.92 [0.81-1.05],0.1968810766448219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,18200,231,1.06 [0.91-1.24],0.4331668834742176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18596,234,1.12 [0.77-1.62],0.5499395315874734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,15653,191,1.07 [0.90-1.28],0.4300370826040369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,15580,187,1.12 [0.95-1.32],0.1676869407559564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,18640,235,0.82 [0.65-1.02],0.0789050187773033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,15614,190,1.15 [0.81-1.64],0.432068977270739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18507,234,1.17 [0.90-1.51],0.2426773480939128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,18575,233,1.08 [0.84-1.38],0.5482261857595048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,16120,197,0.94 [0.76-1.17],0.5995263847369973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,15789,194,0.79 [0.65-0.95],0.0120455888687518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18763,237,1.05 [0.64-1.72],0.8446084437077078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,16150,196,0.76 [0.53-1.07],0.1135615660822063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,16090,198,0.86 [0.63-1.17],0.3278938334089023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,15730,191,1.03 [0.69-1.53],0.890565801790633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,15656,189,1.41 [0.89-2.24],0.1466083914018375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,15656,189,1.25 [1.00-1.55],0.0467014484649227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,15730,191,0.87 [0.59-1.29],0.4985938175347683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,18178,232,1.00 [0.81-1.23],0.9896264620171024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",18592,236,1.00 [0.88-1.13],0.9949121567131034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,18248,228,1.22 [1.00-1.48],0.055227071352014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,15548,188,1.24 [0.94-1.63],0.1336008720811688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,15653,191,1.22 [0.96-1.54],0.0990757803725119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,15653,191,1.05 [0.87-1.27],0.5910177475370536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,15653,191,0.68 [0.48-0.97],0.0318040617794375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,18309,231,0.96 [0.88-1.04],0.2832552696908424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,15614,190,1.08 [0.83-1.40],0.5787966989804824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,15656,189,0.97 [0.76-1.25],0.8247192061273217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,18819,237,0.84 [0.70-1.00],0.0543235788530206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,15653,191,1.03 [0.74-1.44],0.8516528299787098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,15656,189,0.97 [0.74-1.26],0.8021493176739896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,18286,230,0.79 [0.56-1.12],0.1856287834128288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,15614,190,1.04 [0.78-1.38],0.8044811502908398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,16083,195,1.00 [0.71-1.41],0.9905122587460052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,16110,194,1.09 [0.82-1.45],0.5519888591245956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",18536,234,1.02 [0.92-1.14],0.6845517577092293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,15730,191,0.96 [0.68-1.36],0.834821435124709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,15789,194,0.83 [0.51-1.37],0.4723342137707533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,18763,237,1.03 [0.85-1.26],0.7463103156613096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,18829,238,0.96 [0.65-1.41],0.8404996775558382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,18414,234,1.07 [0.84-1.38],0.5819067254451415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,18507,234,1.02 [0.89-1.17],0.7273234342260035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,16110,194,1.07 [0.88-1.29],0.4993065514470836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,16120,197,0.99 [0.75-1.31],0.9391929415101792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,18829,238,1.04 [0.85-1.27],0.7070489616933692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18640,235,2.02 [1.42-2.88],9.48228680130396e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,15691,190,1.00 [0.86-1.17],0.9560406263135732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,15691,190,1.05 [0.79-1.40],0.7263266174263174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,15691,190,1.11 [0.85-1.43],0.4461383447882346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,15580,187,0.91 [0.65-1.27],0.5772864857497084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,18761,237,1.00 [0.87-1.16],0.9573345192995912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,16110,194,0.76 [0.63-0.93],0.0063775522084993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,18507,234,0.91 [0.79-1.04],0.1622177953038096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,16090,198,0.99 [0.79-1.23],0.9281856408760224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,15789,194,0.76 [0.58-1.01],0.0543327116899054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,15647,194,1.08 [0.91-1.28],0.3622478674095628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,18267,228,1.05 [0.85-1.29],0.6640575044792765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,16110,194,1.05 [0.74-1.50],0.768600422721297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,15691,190,1.00 [0.84-1.19],0.9819366061424164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,16090,198,0.95 [0.79-1.13],0.5449207257335402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,18538,235,1.32 [0.84-2.05],0.2267610613267143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,15653,191,1.11 [0.95-1.29],0.1745292906246461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,16090,198,1.04 [0.92-1.18],0.5234373441359534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,16120,197,1.06 [0.84-1.36],0.6125039599705074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,18447,234,0.99 [0.81-1.20],0.8870139640186754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,16110,194,0.87 [0.68-1.12],0.2884105522716409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18623,235,0.83 [0.66-1.05],0.1225532346060341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,15730,191,1.10 [0.76-1.59],0.6143085748616746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,15653,191,1.09 [0.98-1.22],0.1157715590233669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,16110,194,0.99 [0.90-1.10],0.9186512699003984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,18596,234,0.99 [0.90-1.09],0.908480675178948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,18419,234,1.06 [0.82-1.36],0.6592432612886088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,18507,234,1.22 [0.84-1.79],0.3012021665256482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,18592,236,0.99 [0.72-1.36],0.96053738012864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,18274,230,1.17 [0.75-1.80],0.4903613221156546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,18507,234,0.91 [0.65-1.28],0.6032876675888945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,18455,232,0.99 [0.82-1.20],0.927001390874243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,18829,238,1.58 [0.98-2.53],0.0587365226867993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18719,234,1.21 [1.01-1.45],0.0350561671250183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,18447,234,1.11 [0.84-1.46],0.4611969213335882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,18507,234,0.96 [0.78-1.18],0.6788100548882345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18368,235,1.43 [1.04-1.98],0.029867949150748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,16120,197,1.21 [0.83-1.77],0.3239871175904747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,18598,236,1.11 [0.73-1.69],0.6364098607229036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,18711,234,0.91 [0.65-1.27],0.5864381154574463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,18442,234,0.82 [0.65-1.04],0.1044505976953701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,15789,194,1.11 [0.94-1.30],0.2130686836226921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,16045,195,0.84 [0.60-1.16],0.2836752865094356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,15730,191,1.00 [0.78-1.26],0.9692311912498366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18507,234,0.99 [0.61-1.61],0.9642819000976148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,16144,199,1.00 [0.81-1.23],0.9952475584789334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,18267,228,1.01 [0.86-1.20],0.8686261022853875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,16083,195,0.99 [0.71-1.38],0.9662876563883552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,15730,191,0.76 [0.59-0.97],0.0305839398282839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,18200,231,0.99 [0.87-1.14],0.9200872584668864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",16090,198,1.01 [0.89-1.16],0.8529359571179924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,16110,194,1.11 [0.82-1.51],0.5072291507354036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,16083,195,1.09 [0.82-1.45],0.5576432391522906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,15730,191,1.08 [0.91-1.29],0.3586669028406953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,16083,195,1.12 [0.82-1.53],0.4611488363316891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,18447,234,1.01 [0.89-1.14],0.9084694957744972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18748,235,1.13 [0.77-1.65],0.5461681370138063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,18200,231,1.11 [0.81-1.54],0.5158114200278147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",16144,199,0.96 [0.79-1.16],0.6492165845796173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",15691,190,1.02 [0.88-1.18],0.8272007047398701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,15614,190,0.98 [0.77-1.24],0.8689559106202389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,15746,197,1.29 [0.87-1.90],0.2049178359875519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,15653,191,1.10 [0.87-1.40],0.4314337809649698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,18771,235,1.16 [0.88-1.53],0.2893119847907499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18592,236,0.98 [0.86-1.12],0.8039441035908508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,16083,195,0.84 [0.66-1.07],0.1497270800255954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,15614,190,0.93 [0.63-1.39],0.7388394234562542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,16120,197,1.17 [0.98-1.40],0.0862970356023229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18267,228,1.54 [1.13-2.09],0.0062082300870223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,15691,190,1.22 [0.77-1.94],0.4052485106991376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,15656,189,1.14 [0.85-1.53],0.3919867854651861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,16144,199,1.03 [0.89-1.20],0.6664527541346078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,16090,198,1.37 [0.94-1.99],0.1005603424453839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,15865,196,1.18 [0.80-1.74],0.3993640536473405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18656,235,1.23 [0.86-1.75],0.2503383852957576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,16120,197,1.31 [0.92-1.86],0.1323800786539105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18567,236,1.58 [1.10-2.27],0.0139170974581002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18412,233,1.35 [0.95-1.92],0.0955721041255323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,15730,191,1.03 [0.81-1.33],0.7922058259672026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,18547,235,0.96 [0.86-1.07],0.462485293517334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,18178,232,1.00 [0.74-1.36],0.9781510719728584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,16090,198,0.79 [0.50-1.26],0.3272420762680695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,18829,238,2.16 [1.06-4.41],0.0341436607121299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18592,236,0.97 [0.77-1.20],0.7518635893643578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,16144,199,1.04 [0.87-1.25],0.6596483143890105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,15691,190,1.01 [0.89-1.14],0.8764572941199344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",16110,194,1.19 [0.96-1.49],0.1168790057539755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",16033,197,0.96 [0.84-1.09],0.5121884314012267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15614,190,0.98 [0.78-1.21],0.824161237398078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,15691,190,0.98 [0.70-1.36],0.8853101797036672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,18447,234,0.83 [0.67-1.03],0.0886522715126185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,15656,189,1.01 [0.85-1.18],0.9401393070340855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18596,234,0.77 [0.64-0.94],0.0085049975508787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18819,237,0.97 [0.86-1.09],0.5725979087829585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,16120,197,0.94 [0.76-1.17],0.579960650867493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,15614,190,0.98 [0.70-1.37],0.9208137452998352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,18286,230,1.02 [0.70-1.50],0.9013033959328126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,16120,197,1.02 [0.87-1.20],0.8192528497623529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,15653,191,1.03 [0.87-1.21],0.7547367555421685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELN,Elastin,16144,199,1.57 [1.07-2.30],0.0218879196411178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,18507,234,1.09 [0.89-1.33],0.4249421590213061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,15614,190,1.27 [0.93-1.73],0.1369309470693854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,18286,230,0.96 [0.75-1.24],0.7684593172607717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,14900,189,0.70 [0.55-0.90],0.0054384281741083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,18829,238,1.11 [0.57-2.15],0.760225436005145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,18582,235,0.98 [0.85-1.14],0.8391628237478896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,18763,237,0.94 [0.78-1.13],0.5134209767923947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,15691,190,0.90 [0.71-1.15],0.4155259811311185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,16083,195,1.07 [0.83-1.36],0.6152780875444064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15614,190,0.88 [0.53-1.49],0.6411107568568368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,15614,190,1.07 [0.79-1.45],0.669560315243227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18829,238,1.62 [1.03-2.53],0.0350578913106131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18657,235,0.80 [0.63-1.01],0.0634879159972477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15691,190,1.09 [0.73-1.62],0.6797334968103135
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,18007,225,0.98 [0.85-1.13],0.7896968469142821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,16083,195,1.16 [0.90-1.48],0.2576668892532783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,18178,232,1.11 [0.84-1.46],0.4684136071610099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,18267,228,1.24 [0.72-2.13],0.4443569185633413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18267,228,0.94 [0.62-1.42],0.7587629825447118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,15691,190,0.75 [0.58-0.98],0.0364838874100365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,15656,189,1.27 [0.83-1.94],0.2646158350466527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,15730,191,0.88 [0.69-1.12],0.3015375782021475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,18562,235,1.07 [0.95-1.21],0.2858722153857759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,16083,195,1.08 [0.82-1.42],0.5685955978526516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,18623,235,1.32 [0.91-1.93],0.1470058582405887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,18200,231,1.11 [0.95-1.31],0.2018871401336402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17944,223,1.76 [1.26-2.46],0.0009824191633877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,15789,194,1.51 [0.94-2.42],0.0871796897917088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,18829,238,1.58 [1.03-2.41],0.0357211091140056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18419,234,1.40 [0.98-1.99],0.0610900565956749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,18267,228,1.13 [0.94-1.34],0.1926369978348533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,15865,196,1.07 [0.79-1.46],0.6463122016248704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18592,236,1.06 [0.91-1.24],0.469239144899324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,15691,190,1.01 [0.83-1.23],0.9205240152271408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18742,234,1.19 [0.81-1.75],0.3748037788223004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,18640,235,1.18 [0.73-1.92],0.4994379254865754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,18505,235,2.66 [1.55-4.57],0.0003645598318285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,18640,235,1.76 [1.08-2.85],0.0222181725817865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,18507,234,0.95 [0.85-1.07],0.4162047756121817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,15730,191,1.08 [0.90-1.28],0.4112393989100673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,15580,187,0.99 [0.65-1.49],0.9467940220099138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,18419,234,1.00 [0.86-1.16],0.981081623848434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,15865,196,0.81 [0.52-1.25],0.3328239712266075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,15656,189,1.04 [0.76-1.42],0.8198350546123032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,16083,195,0.89 [0.60-1.32],0.5531241587796418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,15789,194,1.07 [0.95-1.20],0.2799118714319996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,18481,234,1.06 [0.67-1.66],0.8095579548196514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,15614,190,0.89 [0.62-1.26],0.5010328329090608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,18829,238,1.21 [0.85-1.71],0.2907925194488444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,18567,235,0.76 [0.54-1.08],0.1228533501321733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,15580,187,0.83 [0.62-1.12],0.2295573012163476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,15656,189,1.07 [0.83-1.36],0.6129117345961075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,16110,194,1.10 [0.93-1.29],0.2814605265556075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,15580,187,1.12 [0.80-1.56],0.514729165441679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,15656,189,0.99 [0.84-1.16],0.8564846408999387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,15865,196,0.90 [0.57-1.42],0.6546800630663354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,15614,190,1.01 [0.79-1.30],0.9185307753476994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,15614,190,0.80 [0.57-1.12],0.1893254775893387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18763,237,1.02 [0.62-1.66],0.946247216050172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,16164,199,1.56 [1.11-2.20],0.0105929472880634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,15942,198,1.78 [1.34-2.38],8.85279178798964e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,18598,236,1.00 [0.82-1.24],0.9643890664062786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,16169,200,1.27 [0.90-1.80],0.174285801044446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,16101,200,1.89 [1.10-3.26],0.021379830546695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,16169,200,3.38 [1.37-8.37],0.008456561119046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,18636,235,1.00 [0.81-1.23],0.98665684450803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,18650,234,1.39 [0.89-2.17],0.1423074149403669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,18657,235,2.21 [1.49-3.26],6.843928219039411e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,18663,234,2.26 [1.21-4.23],0.011012762829508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",18567,235,1.01 [0.89-1.14],0.9175716114952692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",18596,234,1.06 [0.92-1.22],0.4477188744191314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",16144,199,0.85 [0.65-1.10],0.2163035436121294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",18829,238,1.27 [1.02-1.57],0.0338104733042759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,18703,237,0.98 [0.82-1.16],0.7860794640627243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,18237,228,1.14 [0.93-1.38],0.1996561085269376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,18592,236,0.64 [0.52-0.80],5.60502006604333e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,18596,234,0.95 [0.81-1.12],0.5423821349439435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,16090,198,0.89 [0.72-1.10],0.2830384124110493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,16120,197,1.02 [0.93-1.11],0.7173094607614436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,16083,195,1.19 [0.75-1.88],0.4665952264473911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,15691,190,1.13 [0.89-1.43],0.3080160350665188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,16144,199,0.79 [0.48-1.30],0.3468585839475384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,18507,234,0.96 [0.69-1.35],0.8310485290589062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,18575,233,1.12 [0.77-1.64],0.5526213467688212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,16090,198,1.03 [0.88-1.21],0.6713416758560886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,18829,238,1.31 [0.86-2.00],0.2020412835484376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,15730,191,1.05 [0.86-1.28],0.6196176495466139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,18769,238,1.22 [0.90-1.65],0.192207351001823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,18819,237,0.97 [0.71-1.32],0.8296905696121983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,16150,196,0.84 [0.55-1.31],0.4492690588406136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,15730,191,0.92 [0.73-1.17],0.5160467522853434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",18596,234,0.91 [0.77-1.07],0.268675616690431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16144,199,1.19 [0.99-1.44],0.0699281580474359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,18592,236,0.93 [0.73-1.19],0.5833299631431723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,16120,197,0.97 [0.54-1.75],0.9272714679599456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18598,236,1.12 [0.89-1.40],0.3449260168382628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,18538,232,1.02 [0.83-1.24],0.8838585966297264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,18178,232,1.09 [0.89-1.34],0.3884108785325569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18630,235,1.32 [1.03-1.69],0.0277533987721666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,16143,199,1.00 [0.79-1.28],0.9795352824404588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,18533,230,1.46 [1.07-1.99],0.0157552603564634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18596,234,1.32 [1.02-1.70],0.0336876095554852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18735,237,1.14 [0.90-1.43],0.2778997491410312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18286,230,1.08 [0.87-1.35],0.4740172887249155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18598,236,0.99 [0.81-1.21],0.9475114051335906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,18592,236,1.04 [0.88-1.23],0.6813292727122979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,18178,232,0.94 [0.78-1.14],0.5562172765700358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",15614,190,1.00 [0.79-1.25],0.9773697544312978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",15614,190,1.03 [0.81-1.32],0.8006609698608236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,18178,232,1.09 [0.93-1.28],0.2773248392384947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,18178,232,0.99 [0.77-1.27],0.9119468938423716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,18663,234,3.15 [2.11-4.70],2.1938000154887096e-08
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,15795,190,1.26 [0.80-1.98],0.3214574128915449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",16120,197,1.00 [0.84-1.19],0.9901837849265523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,15656,189,1.00 [0.74-1.35],0.9905643179532376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,15656,189,1.00 [0.72-1.37],0.9786600022623468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,18657,235,0.95 [0.82-1.10],0.4934558668642562
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18592,236,0.83 [0.70-0.99],0.0373315383147221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,15656,189,1.01 [0.74-1.39],0.9387401831126212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,18748,235,1.03 [0.94-1.14],0.5292201634070773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,18740,234,0.98 [0.79-1.22],0.8776884516421547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,15656,189,1.11 [0.74-1.68],0.604652450371626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,18286,230,0.92 [0.65-1.31],0.6523505285323328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,15656,189,0.77 [0.51-1.18],0.2278483825585713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,15580,187,0.91 [0.75-1.12],0.3759817492495536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,15553,187,0.94 [0.66-1.33],0.7180116449179348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,18640,235,1.22 [0.87-1.73],0.2526260358885345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,16150,196,0.96 [0.73-1.25],0.7533980686551964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,16110,194,1.21 [0.83-1.75],0.3189014556282376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,18640,235,1.31 [0.78-2.19],0.3033897577805984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,15789,194,0.91 [0.69-1.19],0.4855790561545607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,16164,199,1.06 [0.86-1.30],0.6028806432330687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,18200,231,1.09 [0.91-1.31],0.344032161809032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",15653,191,0.90 [0.75-1.09],0.2995001534692509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,15614,190,1.01 [0.76-1.35],0.9385783615015642
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,18200,231,0.96 [0.82-1.14],0.658189898254921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,18565,235,1.00 [0.86-1.17],0.9822069970328052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,16120,197,1.09 [0.95-1.25],0.2233111385856813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,18667,236,0.99 [0.89-1.10],0.8454571337911623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18447,234,0.91 [0.68-1.20],0.4885467453493984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18447,234,0.99 [0.88-1.13],0.9376048895278156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,18172,231,0.96 [0.74-1.24],0.7376183519363911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,16090,198,1.00 [0.79-1.26],0.982585477830708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,18178,232,1.02 [0.91-1.13],0.7736273715306902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18447,234,1.36 [0.91-2.02],0.1314415635577559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,18470,234,0.90 [0.53-1.54],0.6980994370351399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,18178,232,1.03 [0.70-1.51],0.8925675534694189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,18819,237,1.08 [0.78-1.50],0.6482942929441793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,18640,235,1.62 [1.13-2.31],0.0083298709266941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,18200,231,1.02 [0.85-1.22],0.8390977141836629
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,18178,232,0.89 [0.63-1.24],0.4825121405553609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,16169,200,0.97 [0.58-1.62],0.9106242472449096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,16110,194,1.27 [0.95-1.70],0.1094913415426285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,16083,195,1.06 [0.71-1.57],0.7841026115052354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,15656,189,0.93 [0.79-1.08],0.3468713537984222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,18558,235,1.14 [0.77-1.67],0.5197675703683358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,18763,237,1.69 [1.14-2.50],0.0084026205923743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,18582,233,0.98 [0.92-1.04],0.4823916356051829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,15553,187,0.94 [0.63-1.41],0.769732555383529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,18200,231,1.04 [0.76-1.43],0.7908866074062473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,15656,189,0.88 [0.63-1.24],0.4730752629220046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,18592,236,0.96 [0.84-1.10],0.557486826445647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,18178,232,0.91 [0.80-1.03],0.1411207390891359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,15614,190,0.91 [0.74-1.13],0.3914245413424256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,15730,191,1.29 [0.88-1.89],0.1844675411850499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,18390,233,1.19 [0.72-1.95],0.4934900594989284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15691,190,1.46 [1.14-1.87],0.0030700705710657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FST,Follistatin,18636,235,0.97 [0.76-1.25],0.8322435900832833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,15691,190,1.45 [0.78-2.68],0.2407796845533066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,18537,235,1.33 [0.94-1.87],0.1049024722388791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,16072,194,0.83 [0.69-0.98],0.0332105255486537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,18700,238,0.98 [0.85-1.12],0.7210178754199186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,15789,194,0.93 [0.74-1.17],0.5486083983868069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FURIN,Furin,18640,235,1.29 [0.90-1.86],0.1669108654928757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,18147,231,1.17 [0.86-1.57],0.3144745910721503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",15837,195,0.95 [0.75-1.20],0.6538048870424114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18763,237,1.23 [0.96-1.58],0.0961409333854334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",18447,234,1.09 [0.89-1.33],0.3859772750746814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",18771,235,0.99 [0.84-1.16],0.908890839562168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,18286,230,0.97 [0.80-1.17],0.7267886534784762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,18560,236,1.00 [0.88-1.13],0.9658059368244444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,15730,191,0.80 [0.60-1.07],0.1317551407132086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,15653,191,1.25 [0.96-1.64],0.1039717309908346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,16083,195,1.07 [0.80-1.42],0.658864252431831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,15865,196,1.08 [0.89-1.31],0.408946838109769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,15653,191,1.06 [0.85-1.31],0.6171764651827482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,15580,187,1.06 [0.61-1.83],0.838250545752766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,15656,189,0.92 [0.66-1.28],0.6200530988451117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,15865,196,0.82 [0.57-1.16],0.2557929703648597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15691,190,1.19 [0.91-1.54],0.1990030238218123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,15580,187,0.86 [0.67-1.10],0.2403062011904272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,18657,235,0.82 [0.69-0.98],0.0276196029486874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18507,234,0.89 [0.58-1.36],0.5829274515461567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,18771,235,0.71 [0.46-1.09],0.1157542564865819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18286,230,1.28 [0.98-1.67],0.0689444178690559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,16144,199,1.29 [0.82-2.03],0.2644187570092903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,18507,234,1.52 [0.86-2.67],0.1500405654925368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,15614,190,0.87 [0.55-1.38],0.5658805627234433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,15441,188,0.84 [0.53-1.33],0.4557577425384205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,16120,197,1.07 [0.64-1.80],0.7996642872385166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,15865,196,1.34 [1.10-1.63],0.0038975682699288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,18709,237,1.20 [0.76-1.91],0.4393188559246709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,15614,190,1.65 [1.20-2.27],0.0021980199242957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,16110,194,1.08 [0.98-1.18],0.1122208792011506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,15580,187,0.60 [0.35-1.04],0.0674071760028658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15691,190,1.05 [0.87-1.27],0.5845293218159615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,15730,191,1.05 [0.82-1.36],0.6840146411623305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,16082,194,1.02 [0.81-1.27],0.8920117160118364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,18286,230,0.97 [0.80-1.19],0.7849095016232469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,18200,231,1.12 [0.88-1.42],0.3455545237237408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,15614,190,1.07 [0.79-1.46],0.6596544953737454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,16169,200,1.67 [0.99-2.81],0.0545564518892906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,16110,194,1.07 [0.94-1.22],0.3132459474449879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,18178,232,0.98 [0.89-1.08],0.666789036687115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15410,189,0.94 [0.70-1.26],0.6671995126470949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,15614,190,0.81 [0.57-1.16],0.2495202851092122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18507,234,1.03 [0.73-1.44],0.8733131597701671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,18829,238,1.17 [0.93-1.48],0.1777290461448152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,18596,234,1.63 [1.18-2.25],0.0031508850388885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,18200,231,1.06 [0.77-1.44],0.736121138398491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,16144,199,0.88 [0.66-1.16],0.3600650560409802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,18147,231,1.12 [0.88-1.44],0.3591070957767238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,18178,232,0.95 [0.79-1.15],0.6214024040615118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,18178,232,1.08 [0.99-1.18],0.0784000359483356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18748,235,1.92 [1.33-2.77],0.0004920345383951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,18507,234,1.16 [0.66-2.04],0.6061575427745558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,18389,232,0.99 [0.65-1.50],0.9658247153642034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,15646,190,1.15 [0.92-1.44],0.2089631385171441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,18200,231,1.00 [0.84-1.20],0.986116964188408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,16144,199,0.97 [0.80-1.19],0.7917784123617041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,16117,199,0.93 [0.69-1.25],0.6407252239482181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,18302,232,1.53 [1.10-2.12],0.010774206774853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,18567,236,0.83 [0.65-1.06],0.1392029387627462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,18447,234,1.34 [0.82-2.17],0.2413969695387765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,18575,233,0.99 [0.92-1.05],0.6633670330862383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,18178,232,0.98 [0.91-1.06],0.6896002191488584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,15789,194,1.14 [0.69-1.87],0.6142862203835446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,18200,231,0.90 [0.71-1.15],0.4089550877313164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,18596,234,1.10 [0.96-1.27],0.1689491994120729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,16120,197,0.67 [0.41-1.12],0.1280859829493896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,16120,197,1.04 [0.87-1.25],0.6841936505351771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,15789,194,0.96 [0.61-1.53],0.8736935760690497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,15580,187,1.00 [0.75-1.33],0.9729848166996296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,15691,190,1.06 [0.83-1.35],0.6378679003858381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,16110,194,0.93 [0.60-1.44],0.7330408534411663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,16090,198,0.97 [0.84-1.12],0.6965831566850933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,15656,189,0.94 [0.68-1.31],0.727029915687879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,15656,189,0.97 [0.84-1.13],0.6957222118836006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,15580,187,0.94 [0.74-1.20],0.6135452293529605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,17851,223,1.10 [0.72-1.70],0.6561349179579418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,15762,194,0.80 [0.55-1.16],0.2319617567173738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,18447,234,1.08 [0.82-1.42],0.5809836711863494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,15656,189,0.87 [0.54-1.39],0.547832144242345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,18267,228,0.84 [0.68-1.04],0.113712769053848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,18544,235,0.74 [0.53-1.05],0.0924567208540041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,15653,191,1.13 [0.79-1.61],0.5144026072490897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,18474,232,0.79 [0.64-0.98],0.0350049122635199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15789,194,1.09 [0.93-1.27],0.2992636950329124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,18200,231,1.12 [0.89-1.41],0.3330851321581903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,16083,195,0.97 [0.75-1.24],0.7867570309741221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,15759,191,1.13 [0.79-1.61],0.4974594423991354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,16144,199,1.08 [0.89-1.31],0.4308166133981178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,18819,237,0.76 [0.61-0.96],0.021427876072648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,15789,194,0.94 [0.76-1.16],0.5557711158326172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,16120,197,1.01 [0.86-1.19],0.8942799083372666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,18178,232,0.99 [0.83-1.19],0.9385534594980064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,15730,191,1.08 [0.82-1.41],0.5963640214945398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,18598,236,1.02 [0.83-1.26],0.8422560922751944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,15691,190,1.25 [0.91-1.73],0.1727093392772992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,15789,194,1.07 [0.73-1.57],0.7388702942166396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,16120,197,0.98 [0.82-1.17],0.8078459693588681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,18763,237,1.64 [1.07-2.51],0.022593216352159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,18592,236,0.96 [0.86-1.08],0.5279911287013996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,16090,198,1.13 [0.85-1.51],0.3894090278591997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",16150,196,0.61 [0.43-0.88],0.007139227775321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,18542,231,1.37 [0.98-1.93],0.0684357899351289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,15614,190,0.96 [0.78-1.18],0.6731500811405163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,18034,226,0.93 [0.80-1.08],0.3651616982447859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,15789,194,0.99 [0.67-1.45],0.9468459007133354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,18560,236,0.99 [0.87-1.13],0.9188050065900248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,18507,234,1.05 [0.97-1.15],0.2444787439428961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,18771,235,0.94 [0.63-1.39],0.7459695222094953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,18447,234,0.90 [0.73-1.11],0.3117376389848344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,16083,195,1.07 [0.82-1.39],0.6411555032964615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,16090,198,1.27 [0.97-1.67],0.0817619528308431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,16164,199,1.03 [0.77-1.38],0.8435424057076716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,16090,198,1.18 [0.96-1.46],0.1089065007062439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,18200,231,1.28 [0.91-1.79],0.1551482028836869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,18104,229,1.33 [0.89-1.99],0.1679085833432827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,15653,191,1.11 [0.89-1.40],0.3496619890077682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,16120,197,1.30 [0.92-1.83],0.133770333128587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,16090,198,0.95 [0.76-1.19],0.6529583103222989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,18267,228,0.98 [0.82-1.18],0.8246617837565561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,16083,195,0.96 [0.74-1.24],0.7412178647441425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,18596,234,0.98 [0.90-1.07],0.6835343903068155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,16144,199,0.97 [0.78-1.22],0.8080363009830601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",16120,197,1.15 [0.87-1.53],0.3254961494465426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",15653,191,1.21 [0.99-1.48],0.0666243142242518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,18267,228,1.09 [0.86-1.37],0.4676386773709189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18499,236,1.33 [0.82-2.14],0.2507736662468169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,15691,190,1.23 [0.94-1.60],0.1257108951287307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",18507,234,1.15 [0.95-1.39],0.1628628603386892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,15492,186,0.90 [0.75-1.07],0.2306774403564562
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,18178,232,0.90 [0.76-1.06],0.1998183230299395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,16095,198,0.73 [0.35-1.52],0.3973735347728822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",16080,199,1.06 [0.57-1.97],0.8437141427057928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,18566,233,0.88 [0.76-1.02],0.0956088929582789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,18178,232,1.00 [0.85-1.17],0.987315015956032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,15614,190,0.97 [0.80-1.19],0.7935684067621822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,18086,230,0.84 [0.70-1.01],0.0672883301613758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,16110,194,0.99 [0.93-1.05],0.6627845065995063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,15865,196,0.96 [0.77-1.19],0.694219337220499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,15730,191,1.02 [0.85-1.21],0.8534402163082708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,18496,235,1.15 [0.83-1.59],0.3990943428800543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,15865,196,1.04 [0.88-1.24],0.6193558589772401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,15614,190,0.83 [0.55-1.25],0.3832115122576656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,18677,238,0.94 [0.78-1.13],0.4819862344062371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",18267,228,1.00 [0.88-1.14],0.9707568300745042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18819,237,0.81 [0.57-1.15],0.2474063314178118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,18592,236,0.83 [0.68-1.00],0.0487929597156204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18267,228,1.00 [0.85-1.16],0.957038291662028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,15580,187,0.93 [0.69-1.25],0.6187229633385904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",15614,190,1.08 [0.90-1.30],0.4309811673997606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18722,235,0.76 [0.64-0.90],0.0014135527800664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,18771,235,0.93 [0.85-1.03],0.1750822230565821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",18598,236,0.96 [0.82-1.12],0.5908913331679828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,18745,235,1.26 [1.06-1.50],0.0094529620844607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18598,236,1.41 [1.03-1.92],0.032745285393943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,18722,235,0.99 [0.84-1.16],0.9031315426191874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,18771,235,0.83 [0.69-1.01],0.0623259515664139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,16144,199,0.97 [0.85-1.10],0.6010282160401442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,15614,190,1.11 [0.89-1.38],0.3566635337803076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,18819,237,0.92 [0.75-1.14],0.4634817683269775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,15656,189,0.98 [0.77-1.26],0.8972850602551572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,15653,191,0.99 [0.80-1.23],0.9437845877110002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,16090,198,0.92 [0.67-1.27],0.61632327683032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,18736,235,0.90 [0.79-1.02],0.095232414610347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,16110,194,1.12 [0.91-1.39],0.2759641387490806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,18267,228,1.00 [0.79-1.25],0.987457460865166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,15789,194,1.09 [0.65-1.82],0.7380722460353168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,16110,194,1.01 [0.74-1.39],0.945297239576884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,16144,199,1.58 [0.93-2.69],0.0894033980234381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,18592,236,0.93 [0.80-1.08],0.3250919263079874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,18819,237,0.80 [0.57-1.12],0.1940643549502193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,16023,198,1.22 [0.72-2.06],0.4544777077490965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,18178,232,0.96 [0.82-1.12],0.6170329599241597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,16110,194,1.09 [0.91-1.31],0.3295788997039893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,15656,189,0.68 [0.50-0.93],0.0141719355586898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,15614,190,1.32 [0.94-1.85],0.1044244347730966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,16075,194,1.13 [0.86-1.49],0.3758776641508804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,16120,197,1.12 [0.82-1.53],0.4912636852384843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,18267,228,1.33 [0.88-2.01],0.1796957133560199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",16120,197,1.35 [0.89-2.06],0.1611278813517939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18526,232,0.96 [0.70-1.33],0.825313044297553
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18592,236,1.45 [1.00-2.09],0.0481010000080012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,18771,235,0.65 [0.49-0.86],0.0023370695820671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,15759,194,0.93 [0.73-1.18],0.5328775782439417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15691,190,1.12 [0.84-1.50],0.4296427165096783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15614,190,1.05 [0.76-1.44],0.787871617901149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,15542,187,1.02 [0.77-1.36],0.8698277532440672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,18397,232,1.00 [0.78-1.27],0.9729919977220663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18200,231,1.21 [0.96-1.53],0.1149215532079538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,15730,191,0.90 [0.71-1.13],0.3602879613648724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,18362,233,1.09 [0.85-1.40],0.494525836751332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18202,228,0.91 [0.77-1.06],0.2292155577694934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,16120,197,0.99 [0.75-1.30],0.95001846994356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,18819,237,0.99 [0.85-1.16],0.8886062898167637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,18178,232,1.03 [0.76-1.40],0.8594890214809439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,15954,194,1.07 [0.92-1.25],0.3620198369594293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,15836,196,1.04 [0.91-1.19],0.5767248688698441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,15691,190,0.74 [0.46-1.18],0.2079192040987145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,16101,200,1.29 [0.84-1.97],0.2440047552705209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,15691,190,1.06 [0.90-1.24],0.4817499673085762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,18507,234,1.23 [0.90-1.69],0.1940656046572503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18771,235,0.99 [0.71-1.37],0.9340838411905348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,15656,189,1.00 [0.68-1.45],0.9833919545561646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,15691,190,1.02 [0.87-1.18],0.8347837901352021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,18592,236,0.80 [0.60-1.08],0.1434086739877447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,16110,194,1.01 [0.80-1.27],0.9485162274938578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,15614,190,1.15 [0.89-1.48],0.284044928728559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15691,190,0.89 [0.66-1.20],0.4378348609263384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,18116,230,0.93 [0.76-1.13],0.442230702665224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,18623,235,1.00 [0.84-1.18],0.9624203381573796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,16083,195,0.80 [0.53-1.22],0.3084395892880605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,18305,232,1.04 [0.88-1.23],0.6540401421275274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,18771,235,0.78 [0.58-1.05],0.1053675549768102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18482,231,1.28 [0.85-1.93],0.2305185537845552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,15653,191,1.13 [0.95-1.34],0.1589055790700061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,15653,191,1.31 [1.00-1.71],0.0461384409877183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",18640,235,0.99 [0.82-1.21],0.95642716469963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,18523,234,1.47 [0.89-2.43],0.1328755797528028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,18829,238,2.15 [1.33-3.48],0.0018063970645918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,18286,230,0.99 [0.85-1.15],0.8824975480867451
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18537,231,1.49 [1.01-2.20],0.0469231348782143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,18829,238,1.45 [1.02-2.07],0.0411118920377113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18829,238,1.11 [0.72-1.73],0.63432553919523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,18592,236,1.06 [0.84-1.32],0.6401324488471785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,18596,234,0.98 [0.77-1.26],0.8990492194627139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,18507,234,0.98 [0.53-1.81],0.9517750072309564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,15865,196,0.93 [0.65-1.31],0.6707776896178121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,18200,231,0.85 [0.66-1.08],0.1831824002521462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",15691,190,1.01 [0.80-1.27],0.9258035953762336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,18819,237,1.59 [0.42-5.94],0.4937910200847198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,18771,235,1.05 [0.82-1.36],0.6759703214875954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15727,197,1.12 [0.79-1.59],0.5257211057143057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,15865,196,1.08 [0.83-1.40],0.5637614814062119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,15865,196,1.07 [0.74-1.55],0.710767471707757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,16090,198,0.89 [0.51-1.55],0.6744945072330284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,18286,230,1.04 [0.93-1.16],0.5047204667062528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18657,235,1.76 [1.07-2.90],0.0252418819340645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,18447,234,0.91 [0.72-1.14],0.4220813281503152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,18200,231,1.11 [0.86-1.44],0.4201059068785037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,15653,191,1.09 [0.87-1.35],0.4583783097684376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18592,236,1.29 [0.95-1.76],0.1005550025367496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,15614,190,0.99 [0.66-1.48],0.951581085254608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,15730,191,0.99 [0.72-1.36],0.9408717803278616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,16120,197,0.89 [0.71-1.12],0.3295678302894946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,15653,191,1.21 [0.95-1.55],0.1149713797831275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,16150,196,1.01 [0.61-1.68],0.971941042557146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,18507,234,1.51 [0.93-2.45],0.0984029775172299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,15614,190,0.98 [0.72-1.35],0.9122329463913708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,18598,236,1.10 [0.68-1.80],0.6888938785141323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,18804,238,0.93 [0.85-1.03],0.1612202394481519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,18798,237,0.93 [0.76-1.13],0.4475866530207338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,18686,235,2.66 [1.81-3.91],7.0750131500325e-07
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,18370,231,1.27 [1.00-1.61],0.0513842746307294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,18534,231,0.95 [0.66-1.37],0.7841371314073845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,18829,238,1.09 [0.77-1.56],0.6146380789320844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,18596,234,0.99 [0.70-1.39],0.93430277382972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,15656,189,0.91 [0.73-1.14],0.4070532931708902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,15614,190,1.00 [0.78-1.28],0.9895768739837438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,16147,200,0.97 [0.57-1.66],0.9143965856568572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,15580,187,1.09 [0.95-1.24],0.2393759396619785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,15691,190,1.02 [0.72-1.46],0.8942319938284542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18507,234,1.05 [0.74-1.48],0.7869871648432301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,18596,234,0.96 [0.65-1.41],0.8292524352017863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,16144,199,0.94 [0.80-1.11],0.459192179153291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,18592,236,0.90 [0.79-1.02],0.0987033652078073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,18178,232,0.96 [0.83-1.11],0.6009689649540638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18286,230,1.12 [0.97-1.28],0.1294165391795625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,18286,230,1.05 [0.86-1.28],0.6507544045846592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18657,235,1.42 [0.98-2.06],0.0660596340425592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,18286,230,0.95 [0.77-1.16],0.5874250926894435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18507,234,1.07 [0.92-1.25],0.3524521743944974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18819,237,1.10 [0.89-1.36],0.3587084774579421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18286,230,1.36 [1.00-1.87],0.0515382453568544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,15656,189,0.86 [0.59-1.24],0.410810439661039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,18286,230,0.75 [0.55-1.03],0.0726875961321204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,18354,233,1.79 [1.10-2.92],0.0198822234540397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,15653,191,1.48 [0.91-2.40],0.1158789433902409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,18592,236,1.29 [0.92-1.81],0.1465911052309862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18286,230,1.30 [0.93-1.81],0.1214714424607524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18819,237,1.04 [0.80-1.37],0.7603743553910973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,18245,229,1.11 [0.85-1.44],0.4399494729494657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,18286,230,1.02 [0.87-1.20],0.7669862725392403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,18286,230,0.98 [0.69-1.38],0.8994548721181843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,18286,230,1.03 [0.88-1.21],0.7262546376313652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,18598,236,1.37 [1.05-1.79],0.0194411780669924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,18367,234,1.03 [0.83-1.28],0.7950324869144335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,18504,235,1.22 [0.95-1.59],0.1255049521232915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18686,235,1.64 [1.15-2.32],0.0056408949427064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,18819,237,1.02 [0.71-1.45],0.916897291259284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,18332,232,1.05 [0.98-1.12],0.1568689050185441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,18130,229,0.97 [0.82-1.14],0.6772711895412513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,18286,230,1.01 [0.83-1.22],0.9373091733886754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,18201,230,0.96 [0.78-1.19],0.740553208880723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,18567,236,1.82 [1.14-2.91],0.0124227271207651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,18538,235,0.90 [0.51-1.61],0.7299946849119149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,18598,236,1.31 [1.02-1.67],0.0310830439313656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,18769,238,0.68 [0.54-0.87],0.0022924055569745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,18286,230,1.22 [0.89-1.67],0.2253225729360433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,18536,235,1.11 [0.90-1.38],0.3291295549945829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,18286,230,0.93 [0.64-1.35],0.6912680819633363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,18286,230,0.84 [0.64-1.11],0.2239516763252345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,18286,230,0.77 [0.55-1.06],0.1046258223492726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,15656,189,1.03 [0.73-1.44],0.8792478328231268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,15656,189,1.18 [0.96-1.45],0.1156565512976458
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,16083,195,0.99 [0.81-1.21],0.8979959168168395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,18286,230,1.03 [0.79-1.35],0.8045739433133601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,18286,230,1.16 [0.94-1.44],0.1768707528049397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,15521,186,1.04 [0.69-1.59],0.838971231131991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18482,236,1.36 [1.03-1.79],0.030543628274287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,18286,230,1.08 [0.79-1.49],0.6153940887503274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,16083,195,1.00 [0.67-1.50],0.986839697200219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,15580,187,0.95 [0.76-1.19],0.6499624332074729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,15656,189,1.17 [0.93-1.47],0.1746058105033719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,15599,188,1.24 [0.85-1.83],0.2669014787744297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,18592,236,0.93 [0.71-1.22],0.6144412656440048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,18286,230,0.75 [0.55-1.01],0.0578059777755981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,18170,231,1.33 [0.96-1.86],0.0903469327420348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,15656,189,1.01 [0.79-1.29],0.9428893786244772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,15611,189,1.09 [0.89-1.33],0.3909915200915024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,18286,230,1.11 [0.76-1.60],0.5873430556735595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,18286,230,0.95 [0.84-1.07],0.4242363570435784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18592,236,1.19 [0.87-1.63],0.2761290737529758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,18286,230,0.96 [0.87-1.05],0.3515213873563024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,18592,236,0.98 [0.79-1.20],0.8104683747782723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,18507,234,1.10 [0.96-1.27],0.1704456714626648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,18512,231,1.42 [1.01-2.00],0.044423463596232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,18596,234,1.84 [0.95-3.54],0.0688872531357599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,18592,236,1.02 [0.85-1.23],0.8130614181602048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,18598,236,1.13 [0.91-1.42],0.2753414659589359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,15865,196,1.12 [0.89-1.40],0.3455295881079159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18168,230,0.93 [0.76-1.15],0.5273775608879409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,16083,195,0.95 [0.69-1.30],0.7366137380109444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,18447,234,0.99 [0.81-1.20],0.9065899676453568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,16110,194,0.77 [0.60-1.00],0.0460105820391304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,15653,191,0.75 [0.45-1.24],0.2567859117489891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,18172,231,1.19 [0.96-1.48],0.1150428941301312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,15789,194,1.11 [0.86-1.43],0.443087247101522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,18598,236,1.09 [0.81-1.47],0.5761553360327301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,18507,234,0.97 [0.78-1.21],0.7872958801709419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15691,190,0.91 [0.71-1.18],0.4767936287812718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",16120,197,0.72 [0.49-1.05],0.0905710825534987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",18507,234,0.96 [0.85-1.08],0.505401603631203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,16110,194,0.70 [0.61-0.80],6.442641432485312e-07
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,16083,195,0.60 [0.42-0.87],0.006360133516003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,16090,198,1.03 [0.90-1.19],0.6246649310499448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,15656,189,1.18 [0.51-2.71],0.7030118631355669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,18412,233,1.00 [0.88-1.14],0.9761440890494903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,18507,234,0.96 [0.77-1.19],0.6855978996223748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18267,228,0.99 [0.86-1.13],0.8300189897186055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,18286,230,0.85 [0.71-1.02],0.0735486634468151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,18592,236,0.93 [0.83-1.04],0.1912777577460578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17921,226,1.23 [0.90-1.67],0.1932222310233803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,18592,236,1.13 [0.84-1.51],0.425692426718198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,16150,196,0.97 [0.69-1.35],0.8526236139421347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,15963,197,1.05 [0.91-1.21],0.5168558112578419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,18592,236,0.66 [0.47-0.93],0.0159880393631611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,15789,194,1.41 [0.94-2.10],0.0931100678554602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,18598,236,0.99 [0.61-1.59],0.961830559954687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,18592,236,1.08 [0.87-1.35],0.4765884047876114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,15656,189,0.78 [0.58-1.06],0.1147643134222828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,18598,236,1.15 [0.80-1.65],0.454925948606463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,18771,235,1.16 [0.58-2.32],0.6812602944230703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,15865,196,0.86 [0.64-1.14],0.2798551797803635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,18601,235,1.46 [0.85-2.50],0.1691921689923635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,18178,232,1.26 [0.94-1.69],0.129443794268423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,18267,228,0.96 [0.86-1.07],0.4762866962245333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,18508,235,1.04 [0.69-1.58],0.8418775325597796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,18640,235,1.08 [0.79-1.46],0.6429273946222189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,18286,230,0.80 [0.55-1.17],0.2601172112762585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,18771,235,1.24 [0.97-1.57],0.0858725679941534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,16150,196,0.91 [0.64-1.30],0.6089896444497247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,16169,200,2.03 [0.98-4.21],0.0563294401596701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18686,235,1.49 [1.09-2.03],0.0119115517938191
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16169,200,2.34 [1.43-3.82],0.0006950959940748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,16083,195,1.25 [0.95-1.66],0.1113372823201426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,18592,236,1.04 [0.86-1.25],0.6816529086328482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,15614,190,0.87 [0.70-1.08],0.1962754680313068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",15691,190,1.13 [0.93-1.38],0.2280366746213923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",15653,191,0.81 [0.57-1.16],0.2501135408764799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18200,231,1.12 [0.89-1.39],0.3358905200857069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,15580,187,1.13 [0.85-1.50],0.3906568365071625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,18763,237,1.47 [0.98-2.20],0.0601353438851976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,15789,194,1.24 [0.95-1.60],0.1091246179984897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,18286,230,0.90 [0.74-1.09],0.2655106867888849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,15580,187,0.89 [0.68-1.16],0.3815473734720249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,16090,198,0.98 [0.83-1.15],0.7868618959263763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,18286,230,0.88 [0.67-1.15],0.3488331954217534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18507,234,1.12 [0.86-1.46],0.3902073765849135
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,16090,198,0.97 [0.85-1.11],0.6691561341872528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,15653,191,1.19 [0.95-1.48],0.1330687394269467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,15730,191,1.13 [0.96-1.33],0.1280462837837144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,18200,231,1.16 [0.95-1.43],0.143585649339762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,15791,189,0.90 [0.64-1.25],0.5113086169312535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,15656,189,0.87 [0.71-1.05],0.1461261425284931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,18640,235,2.85 [1.77-4.58],1.486907294201734e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,18200,231,1.05 [0.76-1.46],0.7639846012746918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,15580,187,0.81 [0.62-1.05],0.1087573285471993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,15691,190,1.03 [0.82-1.30],0.8019108739156443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,16110,194,1.00 [0.65-1.55],0.9882666849161328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,15865,196,0.91 [0.75-1.11],0.3630211345031928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,15865,196,0.89 [0.53-1.49],0.6528037478622987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,16083,195,1.06 [0.83-1.35],0.6606317443334904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,15614,190,0.91 [0.58-1.42],0.6825687941944456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,15653,191,0.96 [0.78-1.16],0.6507275328799662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,15614,190,1.03 [0.92-1.16],0.5627976149843731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,18507,234,1.01 [0.87-1.16],0.9300584895202908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,16083,195,1.08 [0.93-1.26],0.3221294299685628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,18178,232,1.01 [0.87-1.17],0.9141804216477988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,16090,198,1.02 [0.94-1.10],0.639602630333625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,18178,232,0.92 [0.84-1.02],0.099557248778669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15580,187,0.94 [0.78-1.14],0.5380550581791452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,15653,191,0.92 [0.70-1.21],0.536227690625544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,18200,231,1.30 [0.98-1.71],0.0668556052275308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,18663,234,1.31 [0.88-1.94],0.178056227810275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,18596,234,1.13 [0.82-1.55],0.4510497365665399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,18200,231,1.01 [0.86-1.18],0.8912151619819788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,15653,191,1.06 [0.77-1.47],0.7215070991177714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,16120,197,0.67 [0.48-0.92],0.0142654154241369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,18423,234,0.98 [0.90-1.08],0.7331916692236868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,18586,234,1.09 [0.83-1.45],0.5240610985628631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,18455,234,1.26 [0.92-1.74],0.1541837844944905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,18178,232,1.02 [0.94-1.12],0.5966818959572661
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,18166,230,1.22 [0.95-1.58],0.1254907229441365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,18771,235,1.24 [0.98-1.59],0.078255729353378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,16052,195,1.37 [1.06-1.77],0.0166276122224531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,16150,196,0.44 [0.39-0.51],4.1756530652378705e-34
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,18771,235,1.44 [1.24-1.67],1.4525518364950654e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,18602,234,0.89 [0.61-1.29],0.5253088474047994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,15400,185,0.75 [0.51-1.10],0.1403706739243362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,17968,228,1.01 [0.73-1.39],0.9608761595912412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,15850,196,2.74 [1.54-4.87],0.0005742671440643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18819,237,1.33 [1.00-1.78],0.0514063376203418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15653,191,1.27 [1.06-1.52],0.0086562126857146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,18819,237,1.19 [0.94-1.52],0.1549702795014594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,15656,189,1.08 [0.81-1.45],0.5850119850543591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,16110,194,1.39 [1.07-1.81],0.0144537855100845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",17642,223,0.89 [0.58-1.37],0.6041017037146108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",15614,190,1.13 [0.80-1.60],0.4846115755021869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",18507,234,0.93 [0.80-1.08],0.339305411858682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",18561,236,0.95 [0.80-1.12],0.5270472760693969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",18200,231,0.95 [0.75-1.20],0.6777943826644623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",15614,190,0.92 [0.61-1.39],0.709613897518617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",15653,191,1.00 [0.85-1.18],0.999684722018218
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,18565,234,0.80 [0.65-0.99],0.044319143018205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,18819,237,0.94 [0.72-1.22],0.6494095737646868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,18640,235,1.02 [0.69-1.51],0.9184025993124244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,16144,199,1.09 [0.93-1.27],0.2859217531289705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,16049,195,1.08 [0.81-1.43],0.5978122525788925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,18596,234,0.97 [0.81-1.17],0.7523819686634339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18507,234,1.19 [0.90-1.59],0.2233612426050992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18567,235,1.31 [0.99-1.72],0.0564080580016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18447,234,0.94 [0.85-1.05],0.256699654181425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,15614,190,0.99 [0.75-1.32],0.9630760214044998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,18657,235,1.33 [0.95-1.85],0.0925028089894308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,15691,190,1.67 [1.05-2.65],0.0309394491974726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,15715,191,1.33 [0.84-2.12],0.2201735347775411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,18035,228,2.15 [1.19-3.88],0.0107637366564245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,18786,237,0.92 [0.74-1.14],0.4298291178566927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,16083,195,0.95 [0.67-1.36],0.799315598663311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,18286,230,1.08 [0.85-1.37],0.514932943270763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,16083,195,0.92 [0.73-1.16],0.5062885653936633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,18819,237,0.99 [0.85-1.15],0.8782351156574141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,18507,234,0.97 [0.88-1.06],0.5004002500220104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,15656,189,1.02 [0.86-1.20],0.8424513663658713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18419,234,1.11 [0.81-1.52],0.5223104694421825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,18686,235,1.39 [1.14-1.69],0.0010572371978917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,18763,237,1.03 [0.88-1.22],0.6950908177363777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,16164,199,1.88 [1.00-3.54],0.0508771874296964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,16120,197,1.02 [0.81-1.27],0.8877775422498442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,18068,230,1.20 [0.90-1.60],0.2056639497646145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,16150,196,1.25 [0.95-1.64],0.1086709059605303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,18646,237,1.33 [1.06-1.67],0.0137539529449404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,16120,197,1.02 [0.89-1.17],0.8034504470984322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,16144,199,1.24 [1.01-1.52],0.0356818106640408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,18748,235,1.01 [0.81-1.26],0.9430919692391456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,15248,192,1.03 [0.84-1.26],0.7795533231295452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,15653,191,0.99 [0.81-1.22],0.9419839286644222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,16120,197,1.19 [0.84-1.69],0.3398943521921325
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEP,Leptin,18596,234,1.47 [1.24-1.75],8.75353866034322e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,18596,234,1.01 [0.69-1.45],0.9784473187746572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,16120,197,1.16 [0.91-1.48],0.2298296857582243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,18596,234,1.20 [0.87-1.66],0.2753516961940307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,18653,236,1.29 [0.88-1.91],0.1948573860944729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,16169,200,1.59 [1.07-2.35],0.0206941275402938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,18567,235,1.09 [0.89-1.34],0.3812085587835996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,18564,231,0.81 [0.61-1.07],0.1421870785827475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,18763,237,1.11 [0.92-1.34],0.2774914666258424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18578,235,1.42 [0.98-2.05],0.0604342096073266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,18657,235,0.99 [0.71-1.37],0.9431746762436112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,18178,232,1.00 [0.88-1.14],0.9502591818716676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18594,235,0.82 [0.68-0.99],0.0426895719975782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,18200,231,1.02 [0.81-1.29],0.8531659524315386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,18592,236,1.35 [0.83-2.18],0.2233871132429218
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18598,236,1.39 [1.00-1.94],0.0484975040219722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,16150,196,1.00 [0.91-1.10],0.9800291114452806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,15614,190,0.96 [0.71-1.28],0.7646412764649188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18575,233,1.65 [1.15-2.35],0.006224196025227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,16144,199,0.91 [0.76-1.10],0.3233457229741474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18829,238,1.72 [1.13-2.62],0.0119118180827209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18738,237,1.65 [1.16-2.34],0.0051153418281052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18286,230,1.17 [0.90-1.52],0.2363833756144328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,18829,238,0.98 [0.84-1.16],0.8376954573953751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,15691,190,1.29 [1.04-1.60],0.0226127150819912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,16063,198,0.93 [0.74-1.17],0.5276416646120882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,16110,194,1.79 [1.20-2.68],0.0045500875924841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,16120,197,0.90 [0.60-1.35],0.6075571866115714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,15653,191,1.06 [0.85-1.33],0.6073536555434407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",15691,190,1.03 [0.88-1.22],0.7068305199210752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),15811,194,1.06 [0.98-1.14],0.1550143053181964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,18507,234,1.15 [0.92-1.45],0.2287421952023954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,18596,234,1.07 [0.83-1.36],0.6128044774618298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,17951,229,1.13 [0.92-1.37],0.238248479164713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,15614,190,0.99 [0.79-1.23],0.8945694629410923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15614,190,0.97 [0.78-1.20],0.7675011132313785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,15730,191,1.15 [0.85-1.54],0.3702455566552238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16169,200,1.16 [0.70-1.93],0.5607397681471615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18722,235,1.29 [0.94-1.78],0.1126772538293288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,15608,189,0.84 [0.49-1.45],0.5334997154390166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,18507,234,1.21 [0.78-1.86],0.3930156422542799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,18596,234,1.29 [0.95-1.75],0.0998812933941201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,15730,191,1.15 [0.79-1.67],0.4622139878381442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,15730,191,1.11 [0.95-1.29],0.2046639802830362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18763,237,1.09 [0.90-1.32],0.3914364021675121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,18507,234,1.32 [1.01-1.72],0.0416965307528517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,16090,198,1.56 [1.14-2.14],0.0055531865695518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,15730,191,0.98 [0.73-1.31],0.8745970543313741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,16144,199,1.33 [1.02-1.73],0.0328877365576202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,16083,195,0.87 [0.64-1.16],0.3381429945978663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,18286,230,1.18 [0.88-1.59],0.2633645861339211
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15730,191,0.98 [0.69-1.38],0.8951534884962228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,16120,197,1.38 [0.83-2.29],0.2096982381251779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,18178,232,1.08 [0.88-1.33],0.4526541285829607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,15865,196,0.97 [0.81-1.17],0.7754930485133846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18592,236,1.06 [0.79-1.43],0.678812254449413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,18592,236,1.14 [0.85-1.54],0.3819965210300233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,18771,235,1.05 [0.86-1.27],0.6577019613806225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,16083,195,1.07 [0.75-1.54],0.7028153643498087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,18829,238,1.27 [0.90-1.79],0.1661304407166531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,18178,232,1.12 [0.91-1.39],0.2709177328513074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,18475,235,1.29 [0.88-1.88],0.1852017997650445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,18286,230,0.99 [0.74-1.33],0.9556243491998352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,16083,195,1.18 [0.89-1.58],0.2499817646599982
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LXN,Latexin,18364,234,0.81 [0.67-0.97],0.0201254015133195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,18481,235,1.01 [0.75-1.36],0.9570345899018846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18592,236,1.09 [0.81-1.47],0.5803608617604804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18370,236,1.07 [0.71-1.59],0.7562921100457815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,18447,234,0.92 [0.66-1.28],0.6266137643032461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,18178,232,0.84 [0.66-1.09],0.1888235325926629
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,18507,234,1.02 [0.89-1.17],0.7612780071140324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,18200,231,0.99 [0.82-1.20],0.9510529763661524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,18498,233,1.04 [0.74-1.48],0.8074555947694566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,18178,232,1.03 [0.82-1.29],0.7867812378628405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,15653,191,1.00 [0.88-1.14],0.9429335633827444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,15730,191,1.02 [0.89-1.17],0.7609303178150388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16169,200,2.74 [1.42-5.31],0.0027468778831175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,15580,187,0.67 [0.44-1.01],0.0574438902957739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,15789,194,1.04 [0.85-1.27],0.6854483487980251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,15691,190,1.03 [0.71-1.50],0.8849460671241132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18389,233,1.10 [0.88-1.37],0.3967776794813922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,18178,232,0.82 [0.59-1.13],0.22252121163303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,15730,191,1.02 [0.76-1.35],0.9066026693562308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,15865,196,0.91 [0.78-1.06],0.2041921264423571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,18178,232,1.25 [0.99-1.58],0.0643518759175759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,16144,199,1.26 [0.88-1.79],0.2028937790246827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,16083,195,0.98 [0.76-1.25],0.8568035988507103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15691,190,1.37 [0.78-2.40],0.2801307006142038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,16144,199,0.93 [0.74-1.17],0.5250655907204396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",15580,187,1.01 [0.76-1.34],0.940390177265297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,18657,235,1.00 [0.90-1.10],0.9219696048059624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,18640,235,1.21 [0.80-1.84],0.3568430695787842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,15614,190,1.10 [0.90-1.33],0.3476270999168275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15653,191,1.13 [0.73-1.77],0.584104342632007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,15614,190,0.97 [0.77-1.22],0.7796791016564252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,16110,194,1.16 [0.88-1.54],0.2954247504884258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,16090,198,0.94 [0.75-1.17],0.5616444447418616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,18592,236,0.94 [0.83-1.05],0.2633134677340527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,18178,232,0.95 [0.84-1.08],0.4572275511660831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,18419,234,0.96 [0.86-1.07],0.4490983897395407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,15580,187,1.05 [0.75-1.46],0.7901818909013693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,18592,236,0.94 [0.72-1.24],0.6639047924326211
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,15865,196,0.91 [0.75-1.11],0.3560444473594103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,15580,187,0.97 [0.88-1.08],0.5975717296707125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,18200,231,0.97 [0.78-1.22],0.8191685968466799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,18596,234,1.53 [0.97-2.42],0.0690823560935104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",15762,194,1.00 [0.85-1.18],0.9825247044421204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,18419,234,1.11 [0.67-1.83],0.6949574248002925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,18597,235,1.20 [0.81-1.79],0.3594060484153279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,18412,233,0.96 [0.68-1.36],0.8106994130213225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,18178,232,0.94 [0.82-1.07],0.3628809577559724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAX,Protein max,18200,231,1.02 [0.91-1.14],0.7682441966566775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,18829,238,0.75 [0.60-0.94],0.0113155448764933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,15950,195,1.13 [0.99-1.28],0.0634473121264616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,18686,235,1.18 [0.83-1.67],0.3660140487147298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",16120,197,0.85 [0.59-1.21],0.3659511285284879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,15656,189,0.91 [0.77-1.07],0.2552075790295579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,18498,233,1.06 [0.81-1.37],0.6907823105914837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,16090,198,0.71 [0.40-1.26],0.2447962232128936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,18447,234,1.08 [0.91-1.28],0.3770438257674553
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",16082,199,0.78 [0.54-1.12],0.1836377352635896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDK,Midkine,18577,235,1.18 [0.95-1.45],0.1270437791717638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,15730,191,1.02 [0.64-1.63],0.9222867976861194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15691,190,1.09 [0.93-1.27],0.2833441825421124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,18178,232,0.98 [0.84-1.14],0.7714777700280198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,15614,190,0.99 [0.75-1.33],0.9662951607332024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,18567,235,1.02 [0.76-1.37],0.8714850577630036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,15614,190,1.27 [0.87-1.87],0.2152425204763558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,18769,238,1.66 [0.93-2.96],0.0839742168753775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,16144,199,1.20 [0.77-1.87],0.4270097173248549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,15789,194,1.10 [0.61-1.98],0.7456363816891975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,16090,198,1.02 [0.85-1.23],0.8320240804497907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,18596,234,1.07 [0.96-1.19],0.1953064629325777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,18567,235,1.18 [0.72-1.92],0.5107425174006516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,18819,237,1.16 [0.73-1.84],0.5251111011091023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,18598,236,1.01 [0.91-1.11],0.9134659768583848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,18642,234,1.81 [1.00-3.28],0.0501863755111395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,18200,231,1.29 [0.86-1.91],0.2147892388508445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18592,236,0.99 [0.86-1.14],0.8911095080450434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,18748,235,0.80 [0.65-0.98],0.0343496478261969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,18267,228,1.00 [0.77-1.28],0.9693431541631824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,15730,191,0.99 [0.79-1.24],0.944171051941896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,15789,194,0.84 [0.55-1.28],0.4153578740858424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,18829,238,1.01 [0.76-1.34],0.9482316939317296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,18598,236,0.98 [0.75-1.27],0.8592854469128596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,18636,235,0.98 [0.86-1.12],0.7515970257399804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,18592,236,0.99 [0.90-1.09],0.8046849731022595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,18640,235,1.09 [0.80-1.48],0.6012702729908668
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,15730,191,1.00 [0.81-1.23],0.9836015460687252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,18592,236,1.01 [0.93-1.10],0.7610345968634162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,18563,236,0.92 [0.77-1.10],0.373450541245697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,18286,230,0.97 [0.77-1.22],0.8122033313109106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,16083,195,0.99 [0.87-1.12],0.8417687098913975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,16110,194,1.06 [0.92-1.24],0.4158232843334535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,18447,234,0.98 [0.87-1.11],0.7587215547107355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,15656,189,0.78 [0.52-1.19],0.2552103618803185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,15580,187,0.99 [0.79-1.23],0.9217358469888608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,18592,236,0.94 [0.83-1.08],0.3953332407388021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,18507,234,0.82 [0.70-0.97],0.0170109574724494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,17981,230,0.99 [0.87-1.13],0.8713544229781363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,18543,234,1.18 [0.97-1.43],0.10022477128914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,18640,234,1.21 [0.99-1.48],0.0591436292990346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,18200,231,1.54 [1.07-2.20],0.0194983507953397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,16144,199,1.16 [0.90-1.49],0.2579013041525079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,18598,236,0.65 [0.51-0.83],0.0004156527484004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,18243,228,1.18 [0.92-1.50],0.1872334580624073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,18732,236,1.05 [0.90-1.24],0.5139567387236633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,18578,236,1.07 [0.89-1.30],0.4640447394226791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15614,190,0.97 [0.73-1.29],0.8407636634164044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,15730,191,1.02 [0.80-1.30],0.8675569251062085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,15865,196,0.87 [0.62-1.22],0.4219470629968029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,18566,233,1.02 [0.91-1.14],0.7432943706424542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,15789,194,0.96 [0.78-1.20],0.743924193852286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,18771,235,1.21 [0.87-1.69],0.2634174517470556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,16110,194,1.25 [0.79-1.99],0.3373461936930546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,15865,196,1.02 [0.71-1.45],0.9309193865199704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,15580,187,0.89 [0.61-1.31],0.5624768226883197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,15580,187,1.09 [0.92-1.29],0.3320187212239943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,18267,228,1.01 [0.86-1.18],0.94459515586932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,18507,234,0.98 [0.85-1.12],0.7231965142108407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,18636,235,0.99 [0.85-1.15],0.8685906239597087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,18598,236,1.14 [0.90-1.46],0.2732976395641662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,16055,194,1.10 [0.81-1.50],0.5250352531847539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,16164,199,1.38 [0.86-2.20],0.1782344308624638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,15730,191,1.02 [0.82-1.25],0.8853895408003535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",15614,190,1.14 [0.81-1.61],0.446734803579693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",16120,197,0.89 [0.58-1.34],0.569533676651588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",18200,231,1.55 [1.10-2.19],0.0114074423259843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",15542,187,1.16 [0.75-1.79],0.4989668300486544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",16120,197,1.08 [0.90-1.30],0.4102168724675308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",15656,189,0.85 [0.50-1.46],0.5597269930855667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,18474,231,0.98 [0.81-1.19],0.8411213439933449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,15730,191,1.11 [0.78-1.56],0.5652063018109068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,18575,231,0.50 [0.42-0.58],1.8695944771415042e-18
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,18763,237,1.31 [1.02-1.68],0.033098494433226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,18640,235,1.02 [0.86-1.20],0.84564314099721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,15934,196,1.00 [0.81-1.22],0.9639561542607764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,18267,228,0.85 [0.68-1.06],0.138836805993401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,15656,189,1.07 [0.92-1.25],0.3568615053073122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",16110,194,0.70 [0.38-1.29],0.2544700836681358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,15865,196,1.03 [0.91-1.17],0.599332628215217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",16090,198,1.07 [0.92-1.25],0.3896834675003023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,18267,228,0.88 [0.60-1.29],0.502662090828024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,15614,190,0.95 [0.77-1.19],0.6695569716176084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,16090,198,0.96 [0.84-1.08],0.4810934745710497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,16083,195,0.98 [0.85-1.13],0.7764375827993547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,15865,196,1.01 [0.79-1.29],0.9500313172840916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,18200,231,0.96 [0.77-1.21],0.7362818240335536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,18507,234,1.05 [0.99-1.13],0.1127836850825029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,16150,196,0.94 [0.81-1.09],0.4147991920587538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,15580,187,0.80 [0.54-1.20],0.2817393097792543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,18286,230,0.88 [0.76-1.03],0.107234968988359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,15789,194,0.87 [0.55-1.36],0.5320827533601934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",16144,199,0.86 [0.71-1.04],0.1130023344356803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",15691,190,0.89 [0.74-1.06],0.191684493684457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,16120,197,1.03 [0.84-1.27],0.7561060483696112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,16144,199,1.08 [0.94-1.25],0.2580308273071457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,15614,190,0.80 [0.56-1.14],0.2205692216486692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,15580,187,1.12 [0.82-1.52],0.4865211791740358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,16150,196,1.01 [0.90-1.14],0.8192270916158173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",15614,190,1.03 [0.71-1.47],0.8899946431194643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,15691,190,0.92 [0.76-1.11],0.3857679865650372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,15691,190,0.78 [0.58-1.04],0.0866567473613566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,15730,191,1.08 [0.93-1.24],0.3107372995046304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",15730,191,0.86 [0.65-1.15],0.3133833658611491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,16120,197,1.05 [0.74-1.49],0.7772671942119234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,18286,230,0.91 [0.75-1.09],0.3038821114526248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,18598,236,0.85 [0.66-1.10],0.2257413296992606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,15653,191,1.17 [0.90-1.52],0.2395716733155828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,15614,190,0.85 [0.64-1.12],0.2457297964412371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,15789,194,0.95 [0.82-1.11],0.543793626136651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,18618,235,1.13 [0.90-1.41],0.3017221490075344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,18178,232,0.97 [0.77-1.23],0.820096413781384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,15614,190,0.93 [0.70-1.22],0.5891891327600252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,15730,191,1.04 [0.93-1.17],0.501901606296747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18366,233,1.10 [0.91-1.33],0.3422678785573024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,16083,195,0.84 [0.65-1.09],0.1925723123066296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,18596,234,1.06 [0.86-1.30],0.5937812915073486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,15628,188,0.91 [0.69-1.20],0.4919575679709851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,15662,189,0.95 [0.73-1.23],0.6988467129316436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15789,194,1.48 [0.77-2.82],0.2367057300941308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,18178,232,1.03 [0.83-1.27],0.8210181390459202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,16052,198,1.01 [0.72-1.41],0.9710403040667388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,16110,194,0.81 [0.52-1.24],0.3221038908999601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",16120,197,0.97 [0.72-1.30],0.8314976931939646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18640,235,1.52 [1.01-2.30],0.0451738956817628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,18286,230,0.97 [0.77-1.22],0.766827613140216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,18686,235,0.91 [0.64-1.30],0.6039413737447896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,18598,236,0.89 [0.58-1.37],0.5966530210002542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,18763,237,1.12 [0.83-1.52],0.4635503801515881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,18553,236,0.98 [0.85-1.12],0.7559812307955178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,18657,235,1.00 [0.90-1.12],0.9361396925862808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,18286,230,0.87 [0.67-1.14],0.3279907769660941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,18567,236,1.17 [0.87-1.58],0.3071129038066473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,16090,198,1.42 [0.99-2.03],0.056611228796861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,18771,235,1.39 [0.94-2.06],0.102653805889982
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,18200,231,1.08 [0.91-1.29],0.3927982970107863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,16083,195,0.96 [0.76-1.22],0.7524663387600142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,15627,189,1.11 [0.75-1.66],0.6021493908465456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,16090,198,1.04 [0.89-1.21],0.6418496267633576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",18178,232,0.94 [0.80-1.10],0.4257481592902216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,15614,190,0.73 [0.48-1.11],0.1413793574728657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,15614,190,1.01 [0.82-1.26],0.912743418868091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,15656,189,1.17 [0.78-1.77],0.4474729693302429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,18575,233,1.37 [0.95-1.96],0.0878658974250848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,18640,235,1.60 [1.17-2.18],0.0032710748561737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,15656,189,0.85 [0.64-1.13],0.2567392842447578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,15656,189,0.93 [0.61-1.42],0.735666338265389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,18148,231,1.03 [0.80-1.32],0.8103574004242197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,15865,196,1.00 [0.83-1.21],0.9933295733586512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,18640,235,0.95 [0.72-1.26],0.7249810794987064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,18657,235,0.85 [0.57-1.26],0.4164253905851288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,16083,195,0.97 [0.85-1.10],0.6138095847541667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,16120,197,1.24 [0.70-2.18],0.4569725929996551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,16164,199,1.07 [0.88-1.30],0.5241840621247436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,18819,237,0.82 [0.54-1.22],0.3276236831390362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,15656,189,0.89 [0.75-1.07],0.2068003394844028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18592,236,0.92 [0.82-1.04],0.1829591637506414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18286,230,0.93 [0.76-1.14],0.497252040998116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,15691,190,1.00 [0.82-1.21],0.999947513688692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,16120,197,1.20 [0.96-1.52],0.115542286833825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15614,190,0.98 [0.81-1.20],0.8753726337901723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,15865,196,0.93 [0.70-1.22],0.5871784611028384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,18178,232,0.91 [0.71-1.17],0.4751452016821182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",16090,198,1.04 [0.91-1.19],0.5489112767668389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,15614,190,0.94 [0.76-1.17],0.5896073184196196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15614,190,1.03 [0.72-1.46],0.8728962618649497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,18447,234,1.27 [0.50-3.18],0.6174296935740758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,16144,199,1.43 [0.96-2.14],0.0786283249545511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,16110,194,1.40 [0.80-2.44],0.2348133798306695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,15419,189,1.05 [0.67-1.65],0.8347066223443597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,18629,232,0.93 [0.67-1.29],0.6681565789901738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,18598,236,0.96 [0.82-1.13],0.6584544138799255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,18178,232,0.97 [0.78-1.22],0.812808347464806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,15691,190,0.96 [0.70-1.32],0.7965001513804495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,16083,198,1.01 [0.83-1.22],0.9444489573314954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,15730,191,1.01 [0.82-1.25],0.920651025129327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,15653,191,1.05 [0.78-1.41],0.7341051574104648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,15656,189,1.27 [0.67-2.42],0.4615233677742361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,18597,235,1.16 [0.72-1.86],0.5337081926169114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,16017,195,0.98 [0.80-1.19],0.8380343801163207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18447,234,1.00 [0.85-1.17],0.9642106719566806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,15580,187,0.82 [0.54-1.26],0.3701131524454247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,16120,197,1.02 [0.83-1.25],0.8554414790290187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,18598,236,1.54 [0.93-2.55],0.0953535001364463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,15614,190,1.02 [0.91-1.16],0.6984397864533376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",18200,231,0.92 [0.75-1.14],0.4511373125058975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",15614,190,1.33 [0.97-1.83],0.0805990688168687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",18200,231,0.85 [0.67-1.09],0.2038377489303281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18829,238,2.19 [1.08-4.45],0.0299221320451847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,16150,196,1.72 [0.94-3.16],0.0810434939602518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,18829,238,0.95 [0.68-1.35],0.7921298168464557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15885,192,1.20 [0.80-1.81],0.3835274804495767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,18596,234,1.10 [0.78-1.54],0.6005538060883446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,15656,189,1.06 [0.69-1.63],0.7787996954819426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,15656,189,0.93 [0.81-1.08],0.3705038825266746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,16144,199,0.85 [0.63-1.14],0.2815508452486338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,18267,228,0.95 [0.88-1.03],0.1957754862372374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,18592,236,0.81 [0.64-1.02],0.0735639830234589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,15614,190,0.83 [0.57-1.22],0.3448440693496734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,18178,232,0.99 [0.85-1.16],0.8906468203800777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,18598,236,1.01 [0.76-1.34],0.9401253119535176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,16150,196,0.44 [0.29-0.65],5.605285174864832e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,18596,234,0.73 [0.51-1.05],0.0904362788454903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,18771,235,1.13 [0.94-1.36],0.2000328064306313
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,18596,234,1.29 [0.86-1.92],0.2175906139535762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,16164,199,0.99 [0.85-1.15],0.9126087075239274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,16120,197,1.08 [0.75-1.56],0.6765720361047578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,18719,235,1.38 [0.90-2.11],0.1402697370394664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,18598,236,1.56 [1.05-2.31],0.0280765010954158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,18286,230,1.12 [0.89-1.41],0.3273695778550746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,15730,191,1.20 [0.85-1.69],0.3106397699675569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,18763,237,0.86 [0.71-1.03],0.1041852432455782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",16144,199,1.04 [0.86-1.26],0.699762807687632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,16110,194,1.27 [0.85-1.89],0.2509934922209722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,18554,235,0.91 [0.79-1.04],0.1725820801129839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,18640,235,0.89 [0.70-1.11],0.2955030957494975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,18592,236,1.03 [0.74-1.43],0.8520269695732143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,18178,232,0.98 [0.70-1.38],0.9067393790255862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,18596,234,1.31 [0.83-2.07],0.244652680855822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,18763,237,1.72 [1.01-2.95],0.0471965028479858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18596,234,0.91 [0.82-1.00],0.061922330744525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,18592,236,0.95 [0.82-1.09],0.4507065763704764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,16083,195,1.00 [0.87-1.15],0.9703103018988934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,18742,234,1.15 [0.84-1.57],0.3906505577660534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,18819,237,0.93 [0.77-1.11],0.4062266195990318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,15691,190,1.24 [0.74-2.07],0.4173239840545856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,15614,190,0.89 [0.66-1.21],0.4670655304654139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,16065,198,1.04 [0.88-1.21],0.6696978114073797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18507,234,0.80 [0.64-1.00],0.0490117617105767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,18598,236,0.90 [0.71-1.15],0.3957672803711438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,15656,189,1.01 [0.85-1.20],0.9335141448819332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,15614,190,1.17 [0.79-1.75],0.4322005375427536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,15614,190,1.08 [0.69-1.70],0.7338799503687854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,18200,231,0.91 [0.67-1.25],0.5751406802507988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,15656,189,1.41 [0.88-2.25],0.1500577217264589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,18388,233,0.76 [0.63-0.93],0.0064801812983208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,16120,197,1.11 [0.82-1.51],0.4818909606312886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,18170,231,1.15 [0.94-1.41],0.1695394882168371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,15865,196,0.90 [0.71-1.14],0.3934222733965884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,16090,198,0.94 [0.77-1.15],0.5447669128251167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18507,234,0.83 [0.57-1.22],0.3482536936760952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,18598,236,1.56 [1.22-2.01],0.0004445070037238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,15865,196,0.87 [0.69-1.11],0.2634086930338578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,15192,184,1.03 [0.91-1.16],0.659994677780996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,18413,233,1.07 [0.88-1.30],0.5143133145758837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,18657,235,1.10 [0.83-1.47],0.4980606939410854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,18507,234,0.80 [0.68-0.95],0.0105838875809396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,15653,191,0.90 [0.66-1.22],0.4881808941768676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,16110,194,1.02 [0.90-1.17],0.7162998189563864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,15691,190,0.93 [0.75-1.15],0.4838362379445714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,18507,234,0.99 [0.77-1.27],0.9226050543349952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,16106,198,2.46 [1.29-4.69],0.0060197240424421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,16110,194,1.11 [0.79-1.57],0.5449616007384805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18597,235,1.21 [0.87-1.69],0.2605068675288396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,18499,236,1.00 [0.85-1.18],0.9940201736028385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,18719,235,2.38 [1.33-4.26],0.0035970992340603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,15730,191,0.93 [0.65-1.33],0.6884153548141128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,15653,191,0.99 [0.76-1.30],0.9521432076855016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,16090,198,0.93 [0.73-1.19],0.5708393486457575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,16120,197,1.02 [0.82-1.27],0.8595682043496772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15691,190,1.16 [0.96-1.42],0.1324655364456601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,18763,237,0.94 [0.86-1.02],0.1176416186748824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,18495,232,1.15 [0.85-1.55],0.3742579107589074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,15614,190,1.00 [0.79-1.26],0.9879315591221622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,18286,230,0.85 [0.67-1.08],0.1809530229449022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,18170,231,1.02 [0.87-1.18],0.8436463481896574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,18447,234,0.98 [0.88-1.10],0.7347908803780228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,16120,197,1.07 [0.96-1.18],0.2390631554580879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",15865,196,0.99 [0.75-1.32],0.9634332752468996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18267,228,0.92 [0.74-1.14],0.4370243190018346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,15691,190,1.05 [0.75-1.47],0.788022940046037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15553,187,0.84 [0.63-1.12],0.2426440499503628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,18200,231,0.96 [0.79-1.17],0.7007373648711821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,15656,189,0.76 [0.49-1.16],0.2036549891925196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,15992,197,1.61 [1.10-2.36],0.0139711286677771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,16110,194,1.10 [0.76-1.57],0.6153046171392171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,15614,190,1.02 [0.85-1.22],0.8576529056757274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,18746,236,1.43 [0.94-2.17],0.0923326195354244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,18598,236,2.03 [1.30-3.17],0.0017863511211601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,18286,230,0.78 [0.61-1.00],0.0496706615154589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,15865,196,0.98 [0.81-1.18],0.8197989280646614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,18598,236,0.85 [0.68-1.08],0.1827863920604294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18592,236,0.91 [0.72-1.14],0.3912572866190361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,15789,194,0.92 [0.67-1.26],0.5943549832166716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,15580,187,0.76 [0.48-1.20],0.2389321855341999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,18200,231,0.99 [0.78-1.26],0.9647989831292816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,16090,198,1.39 [0.92-2.11],0.1141897844209599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,15653,191,1.00 [0.85-1.19],0.9579529060106324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,15754,194,0.88 [0.64-1.20],0.4213980877243644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,16120,197,1.03 [0.85-1.25],0.7516497129692075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,18754,237,0.98 [0.56-1.71],0.9407353309273778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,16120,197,1.22 [0.71-2.11],0.4687270564289876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,18596,234,1.15 [0.84-1.57],0.3745695143193038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,16090,198,1.20 [0.85-1.69],0.2925484052909401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,16090,198,1.36 [0.91-2.05],0.1372644125586817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,16083,195,1.18 [0.85-1.64],0.3323512627858185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,15580,187,0.90 [0.70-1.15],0.4108217281868646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,16083,195,1.00 [0.74-1.36],0.9964971379697052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,18829,238,1.25 [0.94-1.66],0.1287167867535569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,16090,198,0.96 [0.79-1.15],0.6363684309132407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,16144,199,1.00 [0.86-1.15],0.9731628166613324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18739,235,1.23 [0.93-1.61],0.1438448871696061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,18507,234,1.19 [0.83-1.72],0.3402923429099499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,18763,237,0.90 [0.73-1.10],0.3027984675038305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,18596,234,1.04 [0.88-1.24],0.6360237474511806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,15580,187,1.18 [0.94-1.49],0.162256265322546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15580,187,1.18 [0.93-1.50],0.1800099570123899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",15614,190,1.17 [0.95-1.44],0.1436021728124876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",15789,194,0.97 [0.85-1.11],0.7031045872215126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,18829,238,0.96 [0.82-1.12],0.5817744923687018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,18657,235,0.97 [0.85-1.12],0.7110700840407219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,18178,232,1.75 [1.15-2.66],0.0092874824896322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,18596,234,0.94 [0.62-1.42],0.7711504985750132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,18829,238,1.11 [0.79-1.55],0.5588548427273656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,15580,187,0.84 [0.58-1.22],0.3551574916723875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,15789,194,1.02 [0.58-1.79],0.9482903880283866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,16150,196,1.13 [0.91-1.42],0.2736350016658261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,15580,187,0.93 [0.72-1.18],0.5368492654694117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,16120,197,1.01 [0.90-1.14],0.8502317557346355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,18657,235,1.01 [0.92-1.11],0.870639136348694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",18178,232,0.87 [0.67-1.13],0.2864797370574977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,15730,191,1.05 [0.80-1.36],0.7371781595509154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,15580,187,1.07 [0.84-1.36],0.6007897166865366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,15614,190,1.06 [0.84-1.35],0.604783715226883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15656,189,0.83 [0.59-1.18],0.3017743108180394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,18829,238,1.40 [0.85-2.32],0.1861132662502774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,18598,236,0.82 [0.67-1.02],0.0730763420917702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,18598,236,1.14 [0.78-1.67],0.5092200774549978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,15691,190,1.26 [0.77-2.05],0.360981184079557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,15789,194,1.23 [0.83-1.84],0.3040919469883963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,16164,199,0.92 [0.54-1.56],0.7660503251531278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,15656,189,0.98 [0.88-1.10],0.7584757462353867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,16045,199,1.05 [0.91-1.21],0.5220851442427108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,18200,231,1.09 [0.88-1.34],0.448755576329111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,15580,187,0.79 [0.58-1.07],0.1253728810189483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,15730,191,0.95 [0.76-1.20],0.6854573806322485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18481,234,0.85 [0.73-1.00],0.0450281027794809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,16164,199,1.15 [0.97-1.36],0.1117527187775654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",16144,199,0.98 [0.75-1.28],0.90067400700786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,18819,237,1.27 [0.82-1.95],0.2860494811328656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,18738,237,1.03 [0.79-1.35],0.8322295186331723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,15972,199,0.93 [0.58-1.49],0.7740901750191846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,15614,190,0.94 [0.72-1.21],0.6172631824607298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,15730,191,1.04 [0.83-1.30],0.7303236893375776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,15656,189,0.98 [0.84-1.14],0.7658115922788815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,16120,197,1.01 [0.90-1.14],0.8278553389782443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,16090,198,1.16 [0.89-1.51],0.2618249153657416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,15580,187,1.00 [0.85-1.17],0.9691493120416343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18447,234,1.22 [0.82-1.81],0.3216184339369577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,15789,194,1.11 [0.79-1.57],0.5381127369210089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,16164,199,0.74 [0.42-1.30],0.2930769337000622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI3,Elafin,18358,234,0.85 [0.69-1.06],0.141706310647943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",16120,197,1.04 [0.87-1.24],0.6957615349371256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,18370,234,1.16 [0.84-1.59],0.3732594596210138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18592,236,0.81 [0.66-0.98],0.0299115314581436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18598,236,1.18 [0.80-1.74],0.3946271980832957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,15656,189,0.82 [0.62-1.09],0.1662596534347054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18598,236,1.31 [0.99-1.73],0.055240657250113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,18596,234,1.21 [0.98-1.50],0.0727418350196672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15789,194,0.87 [0.72-1.06],0.1610482736812567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,15553,187,0.96 [0.79-1.17],0.7077997145250968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,16144,199,1.55 [0.93-2.57],0.0913461194698838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,15614,190,1.07 [0.85-1.36],0.5658374577333801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,18602,235,0.79 [0.65-0.95],0.0104999254523218
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,15865,196,1.02 [0.84-1.24],0.8210153305880722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,18447,234,0.87 [0.71-1.07],0.185172605389828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,18640,235,1.22 [0.80-1.86],0.3597221205461672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,18804,238,0.99 [0.77-1.27],0.9298517737776748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",18581,234,1.19 [0.97-1.46],0.0921625082941682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,18657,235,0.99 [0.87-1.13],0.8815496622052754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,18598,236,1.10 [0.78-1.56],0.583116002724164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,18769,238,0.92 [0.73-1.15],0.4581019371322345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,18598,236,1.15 [0.80-1.66],0.4554630529663172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,18454,235,1.30 [0.87-1.93],0.2019151632840622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",16110,194,0.72 [0.57-0.90],0.0040879743555711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",15656,189,1.02 [0.72-1.44],0.9063757145881952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",16110,194,1.04 [0.90-1.20],0.5680157115517792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,16110,194,1.07 [0.87-1.30],0.5252775609828562
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,15770,194,1.52 [0.80-2.90],0.2036989817194407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,18200,231,1.17 [0.84-1.62],0.3668736425679643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,18596,234,1.06 [0.80-1.40],0.6720288883229462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,18596,234,0.90 [0.75-1.07],0.243354442894926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,16081,193,1.02 [0.80-1.31],0.8532558116307323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,18770,237,1.03 [0.75-1.41],0.8668879146117048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,18178,232,0.70 [0.46-1.06],0.0927647273192683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,16110,194,0.77 [0.45-1.30],0.3201052506649881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,18592,236,0.98 [0.85-1.13],0.7580092054469438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,18745,237,1.12 [0.70-1.79],0.6365284546810883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,18535,234,0.99 [0.77-1.26],0.920373352740244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,18519,233,1.03 [0.97-1.10],0.3707988803019661
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,15614,190,0.88 [0.72-1.08],0.2316526783726284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,15614,190,1.07 [0.85-1.36],0.54982326445168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15730,191,1.35 [1.08-1.69],0.009626069515866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,18172,231,1.00 [0.90-1.12],0.9730353101241777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,16164,199,1.00 [0.82-1.23],0.96440125560068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,16110,194,1.18 [1.00-1.39],0.0499321965386021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,18567,235,0.98 [0.94-1.02],0.243411246188935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,15691,190,1.09 [0.85-1.39],0.5029524199642456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,15653,191,0.96 [0.70-1.32],0.7997849736599454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18286,230,0.93 [0.83-1.04],0.2191088495208576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,18507,234,1.44 [0.67-3.10],0.3535134988219608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,18640,235,1.38 [0.92-2.07],0.1189898539900415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,15656,189,1.06 [0.78-1.45],0.6967960931939872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,15656,189,1.31 [0.83-2.09],0.248388968348496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18507,234,1.00 [0.71-1.41],0.9932460213511236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,15691,190,0.91 [0.74-1.11],0.3410938333963853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,16164,199,1.22 [0.74-2.01],0.4412181092819912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,18267,228,1.04 [0.74-1.45],0.8293571935040221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,18657,235,1.23 [0.82-1.87],0.319037547548108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,16150,196,1.17 [0.82-1.68],0.3806502445276734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,16044,199,1.01 [0.86-1.19],0.9139780742942152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,18763,237,0.87 [0.67-1.12],0.2744410955899928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,18611,237,1.00 [0.89-1.13],0.9716050089519986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,15865,196,0.91 [0.71-1.17],0.4607291415451847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",16150,196,1.04 [0.84-1.29],0.7072802914317834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,15656,189,0.69 [0.44-1.10],0.1226059486249039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,18178,232,1.02 [0.70-1.47],0.9184660454633616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,15656,189,0.71 [0.51-0.97],0.0299368834624875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,16144,199,1.04 [0.80-1.35],0.7649193328731579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,18507,234,0.69 [0.57-0.84],0.0002101597024469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,16083,195,1.03 [0.87-1.22],0.7291465206556718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,18640,235,1.02 [0.90-1.15],0.7373169461730811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,15865,196,1.05 [0.86-1.27],0.6340564871669718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,16120,197,1.03 [0.86-1.23],0.7497795245910844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,16120,197,1.32 [0.98-1.76],0.0677842225327285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,18596,234,0.98 [0.85-1.14],0.7966433069704374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,18819,237,0.95 [0.84-1.08],0.4339863911065644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,16090,198,1.01 [0.90-1.14],0.8478044744345075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,18447,234,0.98 [0.73-1.32],0.9088725607718308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,15730,191,1.07 [0.90-1.27],0.4730961676585145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,18531,235,1.07 [0.96-1.20],0.2198867445382056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18178,232,1.29 [1.11-1.50],0.001234397865043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,15580,187,1.05 [0.60-1.83],0.8643532745767963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,16150,196,1.01 [0.70-1.45],0.9578385771245514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,16083,195,0.96 [0.70-1.32],0.799264251938347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,18712,238,1.17 [0.81-1.67],0.4012223533079297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,18072,232,0.85 [0.74-0.98],0.0271560481474679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,15899,194,0.76 [0.60-0.96],0.0190438632537921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18286,230,0.97 [0.82-1.15],0.7509038249510815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",18819,237,0.91 [0.77-1.09],0.2982090155359483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,18771,235,0.87 [0.72-1.05],0.1565088131489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,18286,230,1.13 [0.76-1.68],0.5569377031086107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,18567,235,0.99 [0.61-1.62],0.967720526561435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,16150,196,1.07 [0.82-1.40],0.6091457102041178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,16150,196,1.15 [0.87-1.52],0.3167764880383178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,18286,230,0.86 [0.69-1.09],0.2204540976852126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,15730,191,1.09 [0.72-1.67],0.6804220531710334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,18596,234,1.03 [0.89-1.19],0.6709668999928202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,16075,193,0.99 [0.82-1.18],0.8909440507358147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,18286,230,0.93 [0.71-1.23],0.6247849617230514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,15614,190,0.95 [0.68-1.34],0.7785300240056956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,15789,194,1.05 [0.94-1.18],0.3683210139263896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18178,232,1.00 [0.84-1.20],0.9785813201875632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,18763,237,1.02 [0.88-1.19],0.7672563188927671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,16110,194,1.65 [1.27-2.15],0.0001795518306711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,18663,234,2.48 [1.57-3.90],9.230800780426998e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,15614,190,1.00 [0.65-1.55],0.9955983144779544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,18592,236,0.63 [0.50-0.80],0.0001666145984529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,16169,200,1.92 [1.15-3.19],0.0122769126569105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,15675,190,1.15 [0.94-1.39],0.171361080857467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,15656,189,0.98 [0.72-1.35],0.913010259077456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,15691,190,1.30 [0.90-1.86],0.160035777500016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,18686,235,1.13 [0.94-1.37],0.1981066288250514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,15656,189,0.87 [0.57-1.34],0.5357651642832438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,18536,234,1.07 [0.80-1.44],0.6290985089144094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,16110,194,1.00 [0.70-1.43],0.9979298562364158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,18515,235,1.04 [0.78-1.37],0.7974446422755728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,18200,231,0.98 [0.88-1.09],0.6722991343330189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,18771,235,0.83 [0.53-1.29],0.404737090225569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,18140,232,1.08 [0.86-1.37],0.511253539987691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,15865,196,1.39 [0.92-2.11],0.1222374029946548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,16011,195,1.38 [0.85-2.25],0.1953689015632987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,16090,198,0.98 [0.74-1.28],0.8633869856596905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,16090,198,1.02 [0.97-1.08],0.4854175381788426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,18447,234,1.05 [0.95-1.17],0.3517795077646387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,18592,236,0.99 [0.82-1.18],0.893784241621695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,18178,232,0.85 [0.65-1.13],0.2648985218632498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,15580,187,0.94 [0.60-1.49],0.8035462427029267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,16120,197,0.81 [0.60-1.08],0.1509200176802332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,15730,191,0.95 [0.72-1.24],0.6955354993137897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,18507,234,0.75 [0.60-0.94],0.0116663379068045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,18417,234,0.80 [0.58-1.10],0.171032646370713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,18368,230,0.69 [0.49-0.97],0.0322955821158296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,18592,236,0.73 [0.58-0.92],0.0086656226304013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,15656,189,0.80 [0.62-1.03],0.0865065751150649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,18592,236,0.92 [0.81-1.05],0.2311096198106816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,18178,232,0.93 [0.75-1.14],0.463720534167835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,15224,183,1.07 [0.93-1.22],0.3721429783999187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",18200,231,1.28 [0.87-1.88],0.2035495352806436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18486,231,1.18 [0.83-1.68],0.3473686570541999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,15542,188,0.97 [0.74-1.27],0.8174252258535435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,16144,199,0.99 [0.84-1.17],0.9168282289986738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,15730,191,1.07 [0.90-1.26],0.4554833230082905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,18592,236,1.23 [0.94-1.59],0.1262205858686146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,18200,231,1.08 [0.79-1.48],0.6357429074772689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,18267,228,1.07 [0.85-1.36],0.5524888091011548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,15656,189,0.83 [0.62-1.13],0.2349346829567087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18447,234,0.99 [0.85-1.15],0.8901820972307802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,18636,235,0.99 [0.87-1.12],0.8285786789527725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,15630,189,0.87 [0.59-1.28],0.483704900244974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,16144,199,0.68 [0.43-1.09],0.1063875442868548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,16150,196,1.20 [0.65-2.19],0.5610218434239476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,18829,238,1.52 [1.02-2.26],0.0376519043914307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,16090,198,1.07 [0.81-1.41],0.6549337144723224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,16090,198,1.47 [0.82-2.63],0.1907093034508817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,18560,236,1.08 [0.67-1.75],0.7492966287771918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,18386,234,1.13 [0.81-1.59],0.4720353300862641
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,16110,194,1.24 [0.88-1.76],0.213786975433678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,18829,238,1.48 [0.94-2.33],0.0886856027365933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,16144,199,1.27 [0.83-1.95],0.2674287990669473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,15789,194,0.98 [0.77-1.25],0.858556883375602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,18105,229,0.90 [0.71-1.13],0.3535776997432369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,15865,196,0.89 [0.63-1.27],0.5297556130112542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,18592,236,1.11 [0.87-1.41],0.4079799018051427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,18696,235,0.97 [0.88-1.08],0.6259313010419576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,18763,237,1.09 [0.80-1.50],0.5800854500581513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,16083,195,0.94 [0.72-1.22],0.632651549123135
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,18200,231,0.93 [0.74-1.18],0.5695680844134112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,15691,190,0.80 [0.55-1.17],0.2572186607684538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,15614,190,0.96 [0.84-1.10],0.5935898510093038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,16169,200,1.52 [1.07-2.15],0.0204813342451512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,18504,234,0.90 [0.68-1.19],0.4495436717523821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,18614,238,0.98 [0.64-1.50],0.9151899870637272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,15846,196,1.06 [0.75-1.49],0.7571095624506627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,16144,199,1.15 [0.89-1.48],0.2916084025425043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,16144,199,1.00 [0.88-1.14],0.9584241016497383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,16144,199,1.03 [0.87-1.22],0.7410038093994159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,16083,195,1.01 [0.80-1.28],0.9127443834194752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,15614,190,0.94 [0.76-1.18],0.6007546223174027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,18286,230,1.03 [0.90-1.19],0.6449321415884385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,15614,190,1.10 [0.95-1.26],0.1973802179632507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15653,191,1.12 [0.91-1.39],0.2840929560798548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,16083,195,1.02 [0.75-1.39],0.8782707053850337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,18592,236,1.20 [0.93-1.55],0.1619270580836539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,18200,231,1.26 [1.02-1.55],0.0340116084479682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,15789,194,0.96 [0.79-1.15],0.640481522209012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,18178,232,0.93 [0.75-1.15],0.5041498376704606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,18286,230,0.77 [0.62-0.95],0.0142760442825505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,15730,191,0.99 [0.80-1.22],0.9365901851945304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,18178,232,0.96 [0.74-1.24],0.7297230777958232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,15865,196,0.93 [0.71-1.24],0.6364419869072435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,15656,189,1.21 [0.75-1.94],0.4345925755077555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,16083,195,0.98 [0.73-1.31],0.8780514178655237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,15691,190,0.99 [0.76-1.30],0.9592199700771176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,15653,191,1.43 [0.97-2.11],0.0696422877916744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,18178,232,0.95 [0.73-1.23],0.6900239947277353
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,15656,189,1.04 [0.86-1.27],0.6716038149437475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,15865,196,0.83 [0.63-1.10],0.201299111154141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,18178,232,1.08 [0.76-1.52],0.668140289343087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,18719,235,1.50 [1.22-1.86],0.0001407699596518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,18200,231,1.32 [0.95-1.84],0.1004615840788693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,15580,187,1.04 [0.75-1.44],0.8039060589151991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,18178,232,1.11 [0.92-1.34],0.2865760442787295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,16120,197,1.12 [0.80-1.55],0.514436612520706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,18175,232,0.74 [0.60-0.92],0.0061328105191269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,16120,197,1.03 [0.86-1.23],0.7648517872029608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,15614,190,0.98 [0.71-1.34],0.8846466228183973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,15580,187,0.91 [0.66-1.25],0.5412968753998879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,15730,191,1.00 [0.82-1.21],0.9775169019679744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,18507,234,1.01 [0.87-1.17],0.9141736715860694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,18507,234,1.07 [0.86-1.32],0.5456695718004128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,16090,198,1.13 [0.92-1.39],0.2466085149319304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,15656,189,0.92 [0.72-1.16],0.4716105296610531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,15691,190,1.10 [0.96-1.27],0.1601226578095979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,16083,195,1.03 [0.78-1.36],0.853689260445081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,18267,228,1.06 [0.81-1.38],0.6874622655566022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,15691,190,1.68 [0.87-3.25],0.1202264942831378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,16120,197,0.91 [0.72-1.14],0.4113393597941187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18506,230,1.27 [1.03-1.58],0.0274990507993295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,18829,238,1.13 [0.94-1.38],0.1986690422548769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,18829,238,1.17 [0.99-1.38],0.0674234773771935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,16083,195,1.03 [0.73-1.46],0.8608570516665836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,18597,235,1.38 [1.12-1.70],0.0028885896630826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,15656,189,1.23 [0.95-1.61],0.1217707656011743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18598,236,1.21 [0.83-1.77],0.3166116517184892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REN,Renin,18596,234,0.84 [0.73-0.96],0.0135336123142937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,15656,189,0.99 [0.69-1.43],0.9598845285101636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,15580,187,0.83 [0.54-1.28],0.4071214316880956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18507,234,0.97 [0.71-1.32],0.8452574509735233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RETN,Resistin,18564,235,1.06 [0.81-1.38],0.6902653266462695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",15614,190,0.90 [0.66-1.23],0.5252597148833472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,16083,195,0.85 [0.43-1.66],0.6336485773336811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,16120,197,1.04 [0.87-1.25],0.6583778927286157
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,15865,196,0.86 [0.67-1.11],0.238622720237143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,18763,237,1.43 [1.00-2.04],0.048749793827108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,18763,237,1.07 [0.72-1.61],0.7320432472532266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,16120,197,1.03 [0.81-1.30],0.8336522770376403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,18286,230,0.97 [0.81-1.18],0.7872156649258862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,18352,234,0.98 [0.89-1.08],0.6889449129891877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,15656,189,0.86 [0.61-1.21],0.3780878572727876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,15789,194,0.77 [0.57-1.04],0.09113152681107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,18722,235,0.79 [0.64-0.96],0.0179365662867474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,16144,199,1.08 [0.93-1.24],0.3064698912447552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15614,190,0.97 [0.78-1.20],0.7798912102341489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,16120,197,1.04 [0.78-1.39],0.7994435338530008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,15765,194,0.45 [0.33-0.61],1.8291175366816619e-07
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,16164,199,1.50 [0.93-2.40],0.094073392316349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,15691,190,0.95 [0.71-1.29],0.7502154787635776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,18506,233,1.05 [0.95-1.16],0.3528917230296727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,15652,191,1.20 [0.74-1.95],0.4680108929225923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,16057,199,1.25 [0.86-1.81],0.2418416850366636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,16120,197,1.14 [0.89-1.47],0.2858995484261915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,18744,238,1.29 [0.84-1.97],0.2497806719409168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15691,190,1.34 [0.86-2.07],0.1963292552830038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,15656,189,0.76 [0.51-1.13],0.1730703276355943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,15656,189,0.93 [0.61-1.40],0.718868279873663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,15865,196,1.00 [0.81-1.23],0.977852520825607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,18178,232,0.96 [0.80-1.16],0.7016699397055166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,15865,196,1.03 [0.82-1.31],0.7937255041022913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,15691,190,0.93 [0.77-1.13],0.459306354195133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,18597,235,1.45 [0.91-2.31],0.121046874260448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,18763,237,1.71 [1.06-2.76],0.02669286472264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,15691,190,2.15 [0.97-4.76],0.0586572425905905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18596,234,1.34 [0.93-1.92],0.1109557123172586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,18507,234,0.94 [0.71-1.25],0.682980903148193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,15656,189,1.08 [0.69-1.70],0.7424600190717476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,15865,196,0.89 [0.73-1.10],0.2871502814721309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,15730,191,0.91 [0.63-1.31],0.6207158368580414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15691,190,0.98 [0.67-1.41],0.8988188913337389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,15614,190,1.15 [0.83-1.58],0.403340475355776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,15730,191,1.02 [0.91-1.14],0.7392122621555487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18178,232,1.21 [0.97-1.50],0.0865485980944632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,18178,232,0.97 [0.81-1.16],0.7125290187428182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,15653,191,1.12 [0.96-1.30],0.1593307368829265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,18447,234,0.74 [0.52-1.05],0.0946396518287864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,18771,235,1.13 [0.76-1.70],0.5389777317960001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,18507,234,0.87 [0.58-1.30],0.4945732888247401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,15614,190,1.16 [0.89-1.50],0.27518731771767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",16120,197,1.09 [0.94-1.26],0.2772436847141731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,18771,235,1.39 [1.00-1.94],0.0486394704921639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,18178,232,1.00 [0.89-1.12],0.9763716684338328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,18763,237,0.90 [0.74-1.09],0.2656424044459416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,15614,190,1.12 [0.79-1.59],0.5291497712923798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,18460,233,1.10 [0.87-1.39],0.4114733014258248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,18325,230,1.04 [0.89-1.23],0.6016736633624755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,15656,189,0.87 [0.58-1.33],0.5289663888699792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,16120,197,1.18 [0.91-1.52],0.2081399724933839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,18170,231,1.02 [0.84-1.23],0.8511328559689709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,16083,195,1.07 [0.80-1.42],0.6653161309512776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,18640,235,0.80 [0.65-0.98],0.0345858366223552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,16120,197,0.95 [0.72-1.25],0.6961490836088131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,18267,228,1.04 [0.84-1.28],0.7333640385459355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,16169,200,0.63 [0.30-1.30],0.2088145429167577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,16120,197,1.10 [0.68-1.77],0.6885161729951788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,15653,191,1.31 [1.05-1.65],0.0191681992375796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,18592,236,0.95 [0.80-1.12],0.509610338518916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,15865,196,0.84 [0.68-1.04],0.1144412484898256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,16094,198,1.00 [0.88-1.13],0.9848968592178016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15614,190,1.21 [0.87-1.69],0.2575032983044431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,15614,190,1.09 [0.83-1.43],0.5392116905059341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,15865,196,0.76 [0.60-0.97],0.0290991381028174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,16120,197,1.20 [0.80-1.81],0.3714099641740436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,16119,195,0.94 [0.64-1.38],0.7427380251009775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,18507,234,1.00 [0.87-1.15],0.9788827198238144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,18763,237,1.25 [0.86-1.81],0.2448222086968994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,18200,231,1.12 [0.92-1.35],0.257355757855578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,18094,231,1.27 [0.90-1.79],0.1760037314840812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,18829,238,0.96 [0.72-1.26],0.7487688871169106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,18763,237,1.24 [0.84-1.83],0.2801275956776941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,18693,234,1.11 [0.79-1.57],0.5393975087182328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,18597,235,1.29 [0.92-1.82],0.1448096440093098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,18603,234,0.93 [0.75-1.15],0.5141456478234507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,15614,190,1.12 [0.71-1.77],0.6255651017138419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,15789,194,0.92 [0.55-1.54],0.7519956016018585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,18636,235,0.98 [0.85-1.14],0.7968862824611259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,18286,230,1.19 [0.92-1.56],0.1891169555766074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,15653,191,0.98 [0.81-1.19],0.8727789997861228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,18722,235,0.95 [0.73-1.22],0.6736118240630832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,15653,191,1.29 [1.02-1.64],0.0371077337604832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,15730,191,0.94 [0.55-1.59],0.810123823526326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,15730,191,0.86 [0.56-1.31],0.4755969678787725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,15653,191,0.95 [0.70-1.30],0.746653351273632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,15691,190,1.22 [0.88-1.69],0.2356536442585574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,18178,232,1.00 [0.85-1.17],0.9986334329697726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,15639,188,1.07 [0.80-1.42],0.6422388915281124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,16144,199,1.53 [1.00-2.34],0.0497121854396033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,15691,190,0.88 [0.74-1.05],0.1591314730397166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,18592,236,0.94 [0.75-1.16],0.5521827294698803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCT,Secretin,15730,191,1.16 [0.87-1.54],0.3033356016246054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,18596,234,1.08 [0.81-1.44],0.6182316920036914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18596,234,1.01 [0.79-1.30],0.9130470028233804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,16083,195,0.97 [0.85-1.09],0.5843351582439649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,16090,198,1.10 [0.89-1.36],0.3961431465672086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15789,194,1.38 [0.98-1.93],0.0655846904782911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,15691,190,1.09 [0.90-1.31],0.3814715368779329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,15691,190,1.06 [0.67-1.66],0.8120519218691222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,18829,238,1.14 [0.91-1.44],0.2518890632534658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,16169,200,1.38 [0.77-2.46],0.2775458547230942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16169,200,1.48 [0.80-2.75],0.2166233296605046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,18686,235,1.09 [0.89-1.34],0.4147646636563943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,18592,236,0.58 [0.40-0.84],0.0037162851489471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,18596,234,1.65 [1.07-2.53],0.0221942089179008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,15789,194,1.12 [0.84-1.50],0.4501208104628565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,18507,234,0.91 [0.60-1.39],0.6649489978850744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,18763,237,1.11 [0.76-1.64],0.5849710322300612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,15656,189,1.15 [0.68-1.95],0.6103851505340268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18769,238,0.93 [0.61-1.41],0.7187723078318058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,16120,197,0.89 [0.74-1.07],0.2168093482290033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,15865,196,1.26 [1.03-1.53],0.023080298681478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,16078,194,0.96 [0.62-1.46],0.8350400645975461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,18507,234,1.23 [0.84-1.80],0.2846665103550801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,15872,196,0.44 [0.08-2.55],0.3599275451847158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,18829,238,1.51 [1.14-2.01],0.0041026819066332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,18074,227,1.01 [0.90-1.14],0.8499816647780637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,16126,200,2.85 [1.43-5.67],0.0028878861376683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,15874,193,1.64 [0.91-2.95],0.0966255338231359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,15931,197,1.52 [1.03-2.24],0.0344851410709384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,16169,200,2.58 [1.08-6.14],0.0323061835589662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,16169,200,1.47 [0.71-3.05],0.2988697181007871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,18429,234,0.99 [0.84-1.17],0.9260961463843947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,18543,236,0.99 [0.86-1.12],0.8229433482331104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,18267,228,1.39 [1.09-1.78],0.0090460177435742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,18701,237,0.97 [0.80-1.19],0.8013845199951402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,18819,237,1.07 [0.89-1.28],0.4945527347680073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,18447,234,1.00 [0.70-1.44],0.996981420875958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,16144,200,4.54 [1.89-10.89],0.0007136875894529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,16144,200,1.95 [1.21-3.14],0.0061468666524178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,18829,238,0.96 [0.81-1.14],0.617310362837467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,16144,199,1.12 [0.91-1.39],0.2893367507545424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,15928,195,2.02 [1.23-3.32],0.0052381699688466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,15861,195,6.23 [2.38-16.29],0.0001912353076987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,16144,200,2.92 [1.41-6.03],0.0038340758212352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,15865,196,1.00 [0.89-1.11],0.951687910644592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,15762,194,1.15 [0.71-1.88],0.5612485330470547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,16090,198,1.03 [0.81-1.32],0.8077732364298676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,18200,231,1.00 [0.83-1.20],0.9693092971620318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,18378,232,1.24 [0.85-1.81],0.2588016860034186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,15730,191,1.33 [0.87-2.05],0.1911415269394438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,18640,235,1.30 [0.87-1.96],0.2034656493356959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,18507,234,1.57 [1.00-2.49],0.0524579659144394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,18507,234,0.99 [0.85-1.17],0.9412461038788964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,18379,233,1.11 [0.85-1.44],0.4458842953504187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,15789,194,1.01 [0.71-1.44],0.9624724711478728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,18178,232,1.08 [0.88-1.32],0.4859342787574217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,18178,232,1.16 [0.94-1.43],0.1738226176789007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,18596,234,0.90 [0.76-1.07],0.2361266468283402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,15894,197,1.20 [0.94-1.53],0.1382043544039122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,18178,232,0.94 [0.83-1.06],0.3021194282135425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,18592,236,0.83 [0.66-1.03],0.0890586133347434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15653,191,0.92 [0.72-1.18],0.5094907518225709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,16090,198,0.96 [0.73-1.28],0.7887694550916909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,15770,196,0.96 [0.82-1.13],0.6421070620291803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,16110,194,0.89 [0.72-1.09],0.2594174976598142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,16164,199,0.81 [0.60-1.08],0.1515639042432584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,15580,187,0.92 [0.81-1.05],0.2278046413722161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,15585,189,0.88 [0.72-1.07],0.2078258187253793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,15656,189,0.77 [0.54-1.09],0.143849589837095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,16150,196,1.35 [0.83-2.19],0.2223508235148161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",18636,235,1.00 [0.87-1.15],0.976619672680118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,15865,196,1.03 [0.74-1.44],0.8690659955241249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,18611,235,0.99 [0.77-1.28],0.9406839654710054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18657,235,1.42 [1.08-1.86],0.0110012463327366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18592,236,1.45 [1.03-2.04],0.0312968161296255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,18200,231,1.14 [0.99-1.31],0.0595475005172147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18598,236,1.05 [0.95-1.17],0.3453292170958055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18771,235,1.12 [0.79-1.59],0.5290474321689518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,18596,234,1.10 [0.72-1.66],0.6640913902540486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15691,190,1.24 [0.91-1.68],0.1772726930534316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,18745,235,1.52 [1.03-2.25],0.0347396655640121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,15691,190,0.88 [0.54-1.42],0.5935049071628307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18646,236,0.98 [0.80-1.20],0.863828099736712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,18533,235,1.22 [0.96-1.55],0.1056646995480764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,15656,189,0.91 [0.75-1.10],0.3272530226396625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,18507,234,0.93 [0.81-1.06],0.2632014831098012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18200,231,0.97 [0.77-1.22],0.7767543986720274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,18286,230,0.85 [0.68-1.06],0.1524098689803616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,18419,234,0.88 [0.74-1.04],0.1272354573459952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,18657,235,1.02 [0.91-1.14],0.693973593794736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,15614,190,0.80 [0.53-1.19],0.2738023585558515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,16120,197,1.04 [0.91-1.19],0.5531783154517698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,18286,230,1.06 [0.87-1.29],0.5578748865171281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,18178,232,1.19 [0.87-1.62],0.2813372321138107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,18592,236,1.05 [0.86-1.28],0.6326616774144747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,18178,232,0.92 [0.74-1.14],0.4354380253349214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,15614,190,1.37 [0.87-2.16],0.1689678333046115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,16083,195,1.09 [0.89-1.35],0.3974530949909109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,18200,231,0.92 [0.74-1.16],0.481834988314018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,15730,191,1.09 [0.83-1.42],0.5364859951685694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,18200,231,0.94 [0.78-1.13],0.5095623803363524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,15580,187,0.85 [0.65-1.11],0.238858765373904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,15580,187,0.80 [0.57-1.13],0.2003489058548395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,18200,231,0.93 [0.66-1.33],0.6965265788739967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,18592,236,1.02 [0.81-1.28],0.8734356665085787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,15730,191,1.08 [0.89-1.32],0.4357222093770591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,16150,196,0.78 [0.59-1.05],0.1039200673040804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,15614,190,1.12 [0.93-1.35],0.2138413954112648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,15789,194,1.08 [0.92-1.27],0.3570398410942669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,16090,198,1.01 [0.77-1.31],0.9629697289995476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",15580,187,0.84 [0.63-1.12],0.2336163841736425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,18200,231,0.98 [0.78-1.23],0.8620588574194769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,15656,189,1.06 [0.69-1.64],0.7785864594201295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,18771,235,1.27 [0.96-1.69],0.0913890673188301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,18267,228,1.71 [1.25-2.35],0.0007402098623523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,15865,196,1.05 [0.90-1.24],0.5276611967605559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,16090,198,0.97 [0.82-1.15],0.7375979487950673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,16034,193,0.95 [0.64-1.40],0.7881927784391947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,18178,232,1.01 [0.87-1.16],0.93908652581891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,16083,195,0.97 [0.80-1.19],0.7955826396250424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,16083,195,0.94 [0.72-1.23],0.6615676185852207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,18507,234,1.21 [0.66-2.23],0.5413245365849688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,18200,231,1.02 [0.87-1.20],0.8198016796197158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,15580,187,0.98 [0.75-1.30],0.913817193765682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,16090,198,0.94 [0.74-1.19],0.6134254061407097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,18771,235,1.27 [0.90-1.79],0.181681324586076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,18657,235,1.15 [0.86-1.54],0.3319445319731791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,18670,237,0.99 [0.79-1.25],0.9609187099853296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,15656,189,0.86 [0.64-1.15],0.3153384801912832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,18623,235,0.91 [0.77-1.08],0.2939121671129585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,16083,195,1.06 [0.89-1.25],0.529425203933704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,15653,191,1.10 [0.89-1.35],0.3755725258635088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,16076,192,1.00 [0.85-1.16],0.9594284931075558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,18596,234,0.94 [0.83-1.08],0.389470928673672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,15653,191,1.15 [0.86-1.54],0.3331432765894753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,18640,235,1.00 [0.88-1.14],0.9960751819239978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,16120,197,0.89 [0.70-1.14],0.3663977327442801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,15789,194,1.02 [0.91-1.16],0.7075028440814584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,18447,234,1.01 [0.84-1.20],0.9404705611591544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15691,190,1.43 [0.95-2.15],0.0902466992355511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',16110,194,1.09 [0.84-1.42],0.5216589898259778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,15614,190,1.04 [0.84-1.30],0.6982510997011282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,15789,194,0.86 [0.66-1.12],0.2492138002970346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,16090,198,0.65 [0.44-0.95],0.0253821420880014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,16083,195,1.06 [0.91-1.23],0.4781113443617684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,15691,190,1.27 [0.80-2.02],0.3063885556104911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,18596,234,0.92 [0.77-1.11],0.3859247580680669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],18251,229,0.85 [0.66-1.10],0.2263327153574941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",18598,236,1.06 [0.78-1.44],0.7119319812149061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,16164,199,1.06 [0.86-1.31],0.5830568690648725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,16120,197,0.79 [0.53-1.18],0.2548327526787665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,18178,232,1.27 [0.92-1.76],0.1458338635845362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,18689,235,0.76 [0.65-0.89],0.0006182552718725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,18575,233,1.10 [0.81-1.50],0.5545561967195471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,18575,233,0.96 [0.71-1.30],0.8102990096570856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,15730,191,0.87 [0.63-1.19],0.3771353870345728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,16082,197,1.38 [0.82-2.32],0.2214430932693598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,15730,191,1.27 [0.75-2.14],0.3713275820709306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,16120,197,0.91 [0.56-1.47],0.7024962518466418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,16120,197,1.06 [0.84-1.33],0.6323723919412749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,18640,235,0.98 [0.83-1.15],0.7919154219781499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,18622,235,1.41 [0.97-2.06],0.0698274214257349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPART,Spartin,15789,194,0.95 [0.79-1.15],0.61785491435781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,16144,199,1.13 [0.76-1.67],0.5414959359063056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,18598,236,1.19 [0.91-1.55],0.201124867277571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,15789,194,0.76 [0.51-1.13],0.1756723335929549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,18592,236,1.00 [0.84-1.19],0.9698550347134532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,18598,236,0.91 [0.65-1.26],0.5628644657393482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,18771,235,1.07 [0.85-1.33],0.5656982053839121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,15614,190,1.17 [0.80-1.72],0.4063621348349793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18532,236,1.10 [0.71-1.71],0.6663106015548681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,18657,235,0.89 [0.66-1.21],0.4633750068394797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,16090,198,0.76 [0.71-0.82],2.0257651429758642e-13
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,18447,234,0.65 [0.41-1.01],0.0543955919285835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,18597,235,1.41 [1.01-1.98],0.0425198603765812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,18514,233,1.16 [0.83-1.61],0.3881763330980745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,18798,237,1.29 [1.00-1.66],0.0504005019724805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",15656,189,1.01 [0.72-1.41],0.9703118159712169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,15580,187,0.92 [0.72-1.18],0.5191356688114384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,15865,196,0.92 [0.77-1.10],0.3742334219169266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,16110,194,1.05 [0.85-1.30],0.6649567797486557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,18286,230,1.03 [0.90-1.17],0.6866638952760797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15653,191,0.90 [0.57-1.40],0.6339275708026931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,16110,194,1.21 [0.89-1.66],0.2260770817443514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,18611,235,1.01 [0.91-1.11],0.9092874522959964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,18507,234,0.98 [0.80-1.19],0.8091256944289525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,18592,236,0.93 [0.80-1.07],0.3039098963898297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,16144,199,0.94 [0.67-1.31],0.7101311968018318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,18200,231,0.98 [0.80-1.19],0.8153879570122876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",15656,189,1.05 [0.70-1.58],0.8046685635780727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18575,233,1.02 [0.93-1.12],0.65655746283389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18686,235,1.48 [1.13-1.95],0.0050477664983658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,15580,187,0.65 [0.38-1.11],0.1156075352191333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,16090,198,0.92 [0.70-1.21],0.5438236486927923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,15789,194,0.90 [0.69-1.16],0.4019523491445724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18507,234,1.11 [0.85-1.45],0.4322009126233146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18829,238,1.60 [1.16-2.21],0.0039783355102919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",15656,189,0.94 [0.70-1.26],0.658974686799641
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,16150,196,1.48 [0.90-2.44],0.1266261303398908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,16083,195,0.74 [0.48-1.12],0.154966719999696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,18419,234,0.87 [0.72-1.05],0.1561823721683981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,15656,189,0.98 [0.81-1.18],0.817286408157693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,18507,234,0.96 [0.88-1.05],0.4089669043517047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,15580,187,0.94 [0.75-1.18],0.5986514085979175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18763,237,1.03 [0.80-1.33],0.8025576048092666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,18573,233,1.27 [0.77-2.07],0.3503561448718588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,15653,191,1.09 [0.91-1.31],0.3485442264889887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,18563,236,0.90 [0.75-1.08],0.2596396597296494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,18267,228,0.99 [0.84-1.17],0.903296456769502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,18200,231,1.00 [0.82-1.21],0.9677655150473884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,18596,234,1.01 [0.88-1.15],0.9068612101417028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",15580,187,0.98 [0.84-1.15],0.7992740297621738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,18178,232,0.97 [0.79-1.20],0.7912941279774406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,15730,191,1.12 [0.80-1.57],0.5190134957869887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,16110,194,0.94 [0.65-1.37],0.7634218010588186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,18507,234,0.90 [0.73-1.11],0.3118633657088677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,15656,189,1.06 [0.75-1.49],0.7577845298800112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,18178,232,0.93 [0.77-1.12],0.4467320533914901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,15656,189,0.93 [0.70-1.25],0.6491063332706749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,18592,236,1.07 [0.84-1.36],0.6088165856658447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,16120,197,1.11 [0.93-1.33],0.2627302915261891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,18178,232,1.08 [0.83-1.41],0.580403858632371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,16090,198,0.71 [0.49-1.04],0.0758641857114679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,18178,232,0.95 [0.82-1.10],0.4852341715633614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,18763,237,0.98 [0.89-1.07],0.6164024008361031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,18592,236,0.84 [0.67-1.05],0.1274474388478728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,15656,189,0.99 [0.79-1.25],0.9418623861347456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,18763,237,1.00 [0.80-1.25],0.9951541545281632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",16120,197,0.87 [0.69-1.10],0.2306235655677529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,18267,228,0.90 [0.71-1.15],0.3988704186141165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,18598,236,1.28 [0.87-1.91],0.2137450958497549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,16083,195,1.21 [0.88-1.66],0.2494534684833425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,15718,194,1.35 [0.90-2.02],0.1499139028818398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,15730,191,1.17 [0.95-1.44],0.1300756390213448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,16090,198,1.05 [0.73-1.53],0.7819156210894487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,15789,194,1.12 [0.88-1.42],0.349026730394092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,15653,191,1.14 [0.91-1.43],0.2410067973289608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,16110,194,0.98 [0.70-1.37],0.8927412768722965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,16144,199,1.15 [0.96-1.38],0.1228428681715754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,15865,196,0.94 [0.82-1.07],0.3464090074392333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,18507,234,0.95 [0.86-1.05],0.3520887203007152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,16481,207,0.66 [0.42-1.01],0.0566626423427356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,16083,195,1.06 [0.75-1.49],0.7466621047788091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,18507,234,1.17 [0.86-1.59],0.3075139090039158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,15580,187,0.84 [0.65-1.07],0.1614621802332991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,16102,196,0.92 [0.67-1.28],0.6248177785528344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,18286,230,0.92 [0.77-1.09],0.3336195849790159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,15865,196,0.92 [0.71-1.20],0.5461477820796727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,18200,231,0.97 [0.83-1.13],0.7012618555480299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",15730,191,1.09 [0.92-1.30],0.2979317661864942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",16083,195,0.94 [0.65-1.37],0.7574802888081503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,16110,194,0.95 [0.76-1.20],0.6703441894467896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,18200,231,0.68 [0.50-0.91],0.0096874031936253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,18507,234,0.98 [0.86-1.12],0.7766588100584966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,18592,236,1.04 [0.89-1.20],0.6363597473335236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,15789,194,0.98 [0.83-1.17],0.8348085064551568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,18447,234,0.97 [0.86-1.09],0.606382862006832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,18447,234,0.94 [0.81-1.09],0.4185063677276324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,18178,232,0.99 [0.86-1.13],0.8324277380635943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,15730,191,0.88 [0.63-1.22],0.4379584587210986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,18423,233,0.96 [0.85-1.07],0.4309830086837979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,18267,228,1.06 [0.93-1.22],0.3856192391466387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,15847,197,1.24 [0.85-1.79],0.2633604154729292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,18798,237,1.16 [0.81-1.66],0.4137262892669726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,16144,199,1.41 [0.96-2.07],0.0778206135113636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,15865,196,1.00 [0.78-1.29],0.975335435218188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,16144,199,1.40 [0.89-2.21],0.1443266284573054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,18200,231,1.06 [0.98-1.14],0.1600866976104151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",15730,191,1.07 [0.74-1.54],0.7366194666919488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,16083,195,1.01 [0.84-1.22],0.9021874000270385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,18200,231,0.93 [0.80-1.07],0.3044705529709782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,15614,190,1.21 [0.90-1.63],0.2037210557619108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,18640,235,1.51 [0.90-2.53],0.1177916196105143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,15656,189,1.50 [0.95-2.37],0.0854576923283442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,15836,196,1.07 [0.95-1.21],0.2818970612855856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,15730,191,0.64 [0.51-0.81],0.0001859320440455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,15865,196,0.91 [0.60-1.36],0.6395945090345062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,16169,200,1.20 [0.64-2.25],0.5644973074404206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,15653,191,0.96 [0.76-1.21],0.7317755680493081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,18521,235,1.12 [0.98-1.29],0.0972731552029083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,18636,235,1.10 [0.90-1.33],0.3499201176397096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,18604,235,1.32 [1.00-1.75],0.0489638296172881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,18570,232,1.64 [1.22-2.22],0.0012242802301649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,18586,235,1.37 [1.09-1.74],0.0077341717667225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,18687,235,1.51 [1.13-2.02],0.0049018807180528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,16083,195,1.19 [1.05-1.34],0.0050902063087736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,18592,236,1.16 [0.90-1.49],0.2406041864371022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,18786,237,0.93 [0.68-1.25],0.6161853897423415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,16083,195,0.96 [0.74-1.25],0.7790648432162157
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,18512,231,1.05 [0.68-1.62],0.8363770546466305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,15656,189,1.03 [0.54-1.96],0.9258924543062976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,18640,235,1.72 [1.28-2.31],0.0003286712335228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,18829,238,1.16 [0.79-1.70],0.440973596574024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18564,234,0.82 [0.71-0.96],0.0127242669915197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,16164,199,1.55 [0.95-2.54],0.0785972542451097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,15553,187,0.97 [0.82-1.16],0.7722063697358064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18596,234,1.44 [1.00-2.08],0.0495369389733526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,18598,236,1.10 [0.82-1.48],0.5110601524326435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,18629,232,1.21 [0.94-1.56],0.1384737044065691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,18512,233,0.81 [0.57-1.16],0.2483376401700112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,18267,228,1.19 [0.88-1.62],0.2480705745778647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,15614,190,1.07 [0.94-1.20],0.2975813302176875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,15537,188,0.90 [0.58-1.39],0.6196730451915464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,16044,195,0.96 [0.82-1.13],0.651575428435667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,18763,237,1.36 [0.92-1.99],0.1205748877970794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,18064,228,1.01 [0.91-1.11],0.9043932969393708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,18829,238,1.22 [0.91-1.65],0.1854655958851049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18172,231,0.99 [0.77-1.29],0.9673510682064286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15865,196,0.98 [0.68-1.42],0.9213904843617718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18686,235,1.58 [1.21-2.06],0.0008011840774103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,16144,199,1.29 [0.93-1.79],0.1290967605125568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,16110,194,0.97 [0.82-1.14],0.7160093097425959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,18427,232,1.32 [0.89-1.95],0.166909583553832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,16144,199,1.03 [0.64-1.63],0.9137803794242004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,18657,235,0.99 [0.91-1.09],0.8905900113669196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,18598,236,0.99 [0.74-1.33],0.9704010666073796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,18545,232,1.73 [1.02-2.92],0.0412465382662145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,18640,235,0.94 [0.82-1.08],0.3980882917366913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,15653,191,1.24 [0.92-1.66],0.1559861899557069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",15865,196,0.83 [0.60-1.17],0.292269265067578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,15656,189,1.25 [0.74-2.12],0.4085703802952184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,15865,196,1.46 [0.80-2.66],0.2130448405439831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,18819,237,0.88 [0.73-1.06],0.1660913462176463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,15656,189,1.49 [0.91-2.43],0.1096587645443912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,15730,191,1.16 [0.91-1.48],0.221686195442093
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,15865,196,1.10 [0.88-1.39],0.3949163204884837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,15614,190,1.22 [0.97-1.54],0.0836885052223356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,15614,190,0.90 [0.69-1.19],0.463714575321457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,16090,198,1.00 [0.88-1.15],0.9658872790907226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,16083,195,1.06 [0.88-1.29],0.534787700929116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,15691,190,0.98 [0.78-1.24],0.8866198722848805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,16120,197,1.13 [0.86-1.49],0.3822167575595204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,15580,187,0.84 [0.58-1.22],0.3538935645753983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,15653,191,1.09 [0.91-1.29],0.3481389287730458
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,16078,194,0.92 [0.64-1.32],0.6405230643301724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,18507,234,0.98 [0.86-1.11],0.7133527422899111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,18357,232,1.22 [0.90-1.66],0.2082781972004357
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,18598,236,1.03 [0.88-1.21],0.7069658710357969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,18686,235,1.18 [0.93-1.50],0.1709967001976717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18242,228,1.25 [0.94-1.67],0.1233862671130595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,16090,198,0.97 [0.73-1.30],0.849082054248635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,18286,230,0.96 [0.70-1.33],0.8194629863642052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,15789,194,1.15 [0.92-1.43],0.2179391031384777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18447,234,1.06 [0.75-1.50],0.7482929624137202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18447,234,1.12 [0.88-1.42],0.3676745552930048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,18640,235,1.16 [0.91-1.49],0.2259272383333155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18819,237,1.09 [0.82-1.45],0.5354231601612881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18567,235,1.20 [0.81-1.77],0.369116403078928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18640,235,1.13 [0.82-1.54],0.4616248812040467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18597,235,1.22 [0.87-1.71],0.2517030290619737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18286,230,1.00 [0.75-1.34],0.9952094998453768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18597,235,1.32 [0.92-1.89],0.1308193815700872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15789,194,1.25 [0.90-1.75],0.1843350683444367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18771,235,1.28 [0.93-1.78],0.1344564006564055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18598,236,1.51 [1.07-2.13],0.0181925628638745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18598,236,1.33 [1.03-1.72],0.0260965016316134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18763,237,1.71 [1.16-2.54],0.0071665637094336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18786,237,1.33 [1.00-1.78],0.0535645096947626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18447,234,1.18 [0.97-1.44],0.0962845138237105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18763,237,1.17 [0.91-1.51],0.2206058561326246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18447,234,1.51 [1.17-1.96],0.0017621201779053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,18819,237,1.61 [1.02-2.54],0.0425985740271593
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,18592,236,1.18 [0.98-1.44],0.0848450099290684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,18819,237,0.84 [0.56-1.28],0.4233212882071717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18657,235,0.96 [0.62-1.48],0.8643364416202072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18798,238,1.63 [1.11-2.39],0.0121515560695203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,18447,234,0.95 [0.78-1.17],0.6497459616776292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16150,196,1.10 [0.76-1.59],0.6233278071070449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,16110,194,1.00 [0.85-1.17],0.992453861663039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,16150,196,1.06 [0.77-1.45],0.7243889329758342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",18267,228,1.01 [0.87-1.16],0.9303775994436906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,15865,196,1.28 [0.87-1.88],0.2093602967367156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,18447,234,1.35 [1.03-1.77],0.0273968450931872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,18598,236,1.30 [0.83-2.03],0.246020152371677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,16144,199,1.11 [0.93-1.33],0.228369195450272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,16090,198,1.07 [0.95-1.20],0.2801827550978204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",15580,187,0.89 [0.65-1.22],0.4534164263815678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,15656,189,1.02 [0.85-1.22],0.8406616808710653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,15691,190,1.12 [0.87-1.44],0.3707805865908805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,18178,232,0.94 [0.71-1.24],0.6705351432811887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15656,189,0.93 [0.78-1.10],0.3920748993561717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,15443,188,0.94 [0.71-1.25],0.6779921265187859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,18267,228,1.26 [0.88-1.79],0.2059753218720734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,15730,191,1.03 [0.68-1.57],0.8763261469250654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,15730,191,0.96 [0.68-1.36],0.8335302937247837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,15789,194,1.09 [0.96-1.25],0.1886272284439885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,16144,199,1.24 [0.76-2.03],0.3845315663417198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,15614,190,0.96 [0.70-1.31],0.7804205996860037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,18178,232,0.92 [0.78-1.09],0.3277776595768875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,18449,233,0.99 [0.77-1.28],0.9545797784265396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,15865,196,1.05 [0.89-1.24],0.5894283046961892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,18200,231,0.99 [0.73-1.34],0.9235805941539706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,15614,190,0.92 [0.68-1.25],0.5903805922726039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,15580,187,1.01 [0.82-1.25],0.9142909411079088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,18793,237,0.96 [0.77-1.20],0.714909421016342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,16120,197,0.88 [0.60-1.30],0.5314833272166146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,15656,189,0.89 [0.51-1.54],0.678896555469575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,18286,230,0.91 [0.75-1.11],0.3483880862885266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,18592,236,0.80 [0.67-0.96],0.0154535308730408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15656,189,0.96 [0.66-1.40],0.823692325112972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,15614,190,1.15 [0.88-1.50],0.305017757053264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15865,196,1.18 [1.03-1.37],0.0214236861364985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,16150,196,1.11 [0.91-1.34],0.3027359056399882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,18567,235,1.34 [1.09-1.65],0.0063096748835786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,16164,199,0.98 [0.75-1.28],0.8980914586206359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18598,236,1.21 [0.86-1.69],0.271148841253059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,18771,235,1.00 [0.83-1.21],0.9659395385574956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,18592,236,0.85 [0.73-1.00],0.0438500577779204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,15838,196,0.88 [0.71-1.10],0.2745894990898143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,16090,198,0.94 [0.83-1.08],0.391859326656928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,15580,187,0.91 [0.69-1.20],0.5042679319149724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,15730,191,1.03 [0.85-1.26],0.7322570303028225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,18592,236,0.93 [0.81-1.07],0.3050442947176712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,16083,195,0.99 [0.84-1.16],0.8793127448492142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,15614,190,0.87 [0.64-1.19],0.3789896481252691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,15656,189,0.88 [0.70-1.09],0.2439610450828313
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,16120,197,1.04 [0.84-1.29],0.7182654297431819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,18596,234,0.96 [0.82-1.14],0.6503692806930788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,18267,228,1.05 [0.86-1.27],0.6472957280925165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,15614,190,0.77 [0.53-1.11],0.1616054029119132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,18267,228,0.46 [0.37-0.58],8.218208490215568e-12
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,15614,190,0.91 [0.68-1.23],0.5507398906623833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,15653,191,0.93 [0.80-1.09],0.3712375734223679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,16090,198,1.00 [0.87-1.16],0.9815703998401972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,15656,189,1.10 [0.77-1.57],0.6051282758662295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,18171,231,1.02 [0.87-1.19],0.8229011171357841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,15730,191,0.98 [0.74-1.31],0.9013187280698332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTN,Titin,15614,190,0.94 [0.76-1.17],0.5713370419630717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,16004,198,1.17 [0.68-2.01],0.5800563392549625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,15653,191,1.49 [0.95-2.31],0.079464579075551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,16150,196,1.06 [0.90-1.25],0.5121913195130909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,15865,196,1.02 [0.85-1.21],0.8616610063053067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,18447,234,0.97 [0.85-1.11],0.6464555933256806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,15908,198,0.79 [0.56-1.12],0.1899173673286657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,18640,235,0.84 [0.55-1.28],0.4089502156197747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,18763,237,1.08 [0.91-1.28],0.3795757597623195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,16110,194,1.15 [0.89-1.49],0.2783147451214276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,15625,190,1.12 [0.99-1.26],0.0664080740781356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",18598,236,0.94 [0.73-1.22],0.6394923416986127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,18481,232,0.92 [0.77-1.10],0.3684414259575689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,18596,234,1.53 [1.01-2.31],0.0430105220598737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15656,189,1.14 [0.91-1.44],0.2499836971880592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,18507,234,0.60 [0.42-0.85],0.0042353609603681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,16083,195,0.80 [0.48-1.32],0.3762425980076537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,16144,199,1.09 [0.87-1.36],0.4723484430137402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,15656,189,0.96 [0.74-1.24],0.7309782152540809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,15614,190,0.89 [0.68-1.16],0.3795429967750305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,15789,194,0.89 [0.72-1.11],0.2999768108316164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,16090,198,1.03 [0.93-1.14],0.5931252197798995
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,15614,190,1.03 [0.90-1.18],0.6705459157000303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,15614,190,0.84 [0.53-1.31],0.4418850970178047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18447,234,1.49 [1.13-1.96],0.0048970345780639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,18763,236,1.01 [0.81-1.25],0.9576453243369788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,15656,189,1.02 [0.58-1.76],0.9569302260923016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,15580,187,0.91 [0.70-1.19],0.5067133837747204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,16083,195,1.17 [0.80-1.70],0.4121617291281085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,16144,199,0.95 [0.81-1.11],0.5162319814660188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,15653,191,1.21 [0.93-1.58],0.1598768571893738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,15827,196,1.14 [0.91-1.42],0.253002908288076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,15789,194,0.84 [0.68-1.03],0.0974432361507035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,15730,191,0.77 [0.61-0.97],0.0288779868399892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,18507,234,0.99 [0.86-1.12],0.8288324413937807
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,16083,195,0.92 [0.76-1.13],0.43146731384632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,16110,194,1.28 [0.93-1.77],0.123301074458199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,15614,190,0.87 [0.72-1.04],0.124654908593326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,18267,228,0.97 [0.85-1.11],0.6740233003510168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,18178,232,0.96 [0.76-1.21],0.7369545864663238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,18267,228,0.81 [0.62-1.05],0.1169910458788822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,15656,189,0.98 [0.83-1.16],0.8366758363281184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,18592,236,0.97 [0.84-1.12],0.6509073132112655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,18325,231,1.84 [1.21-2.81],0.0045866591465479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,16164,199,1.09 [0.90-1.31],0.3851979875406279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,18507,234,1.61 [0.89-2.92],0.1166908233872131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,15653,191,1.06 [0.92-1.22],0.4291768802214606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18663,234,1.49 [0.98-2.26],0.0618760095362449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,18763,237,1.31 [0.89-1.91],0.1655910000205175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,15580,187,1.17 [1.02-1.34],0.02726221652301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,18764,237,1.01 [0.82-1.23],0.9481194191094164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,15656,189,1.11 [0.69-1.80],0.6566996187500939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,18640,235,1.00 [0.81-1.23],0.975084180493515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,18792,237,1.14 [0.84-1.54],0.3945029305195711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,16120,197,1.23 [0.79-1.89],0.3601047660015624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,18267,228,0.98 [0.89-1.09],0.7591329245715979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,15691,190,1.00 [0.54-1.84],0.9968595125364252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,16144,199,1.02 [0.71-1.45],0.934231189080832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,18507,234,1.08 [0.91-1.29],0.3726911212137985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,16164,199,0.92 [0.77-1.11],0.3952445324046352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,18507,234,0.99 [0.77-1.28],0.9577880953222704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,15865,196,0.90 [0.72-1.12],0.3318091071985098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,18507,234,0.93 [0.80-1.08],0.3631448121992264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,16083,195,1.02 [0.88-1.18],0.7983316981236476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,18507,234,0.98 [0.84-1.14],0.7573809364510282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,16083,195,1.02 [0.68-1.54],0.9086090009270578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15614,190,1.37 [0.94-1.99],0.1046561311813659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,16083,195,1.25 [1.04-1.50],0.0164988692750177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,18573,233,1.28 [0.98-1.66],0.0697851565927256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18566,233,1.03 [0.85-1.24],0.7867698782289725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,16110,194,1.04 [0.72-1.51],0.8168061790430432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,18200,231,1.02 [0.81-1.28],0.8937133416265075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,15865,196,0.91 [0.64-1.29],0.5989873533910011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18267,228,1.22 [1.03-1.44],0.0245642014533264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,18763,237,1.03 [0.88-1.22],0.686176674162633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,18178,232,2.28 [1.64-3.18],1.0483083121451809e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,15789,194,1.03 [0.81-1.32],0.8021454222643429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,18748,235,1.06 [0.80-1.40],0.6922719569568394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,15580,187,0.78 [0.62-0.99],0.0441201946568145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,18384,233,1.51 [1.14-2.01],0.0043253492070508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,16120,197,1.07 [0.80-1.42],0.6549463692033692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,18829,238,0.99 [0.85-1.16],0.9213154908374916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18598,236,0.88 [0.65-1.19],0.3945851128831317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,18286,230,1.08 [0.90-1.29],0.397989873130952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,18267,228,0.95 [0.83-1.08],0.405333935214076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,18200,231,0.98 [0.85-1.13],0.7986299085518764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,16110,194,1.00 [0.83-1.20],0.969210108323148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,15656,189,0.98 [0.77-1.25],0.8847380703950556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,16083,195,0.93 [0.62-1.39],0.709129719427885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,15744,191,1.18 [0.95-1.48],0.1411840884289803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,18736,235,0.72 [0.59-0.87],0.000544549840704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17657,223,1.29 [0.99-1.68],0.0574298907223242
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18378,232,1.26 [0.95-1.67],0.1143847761531709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",18597,235,0.97 [0.69-1.38],0.8800901916416166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,18771,235,1.08 [0.77-1.52],0.6565011014105222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,18286,230,0.87 [0.58-1.31],0.5158860490695871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,18447,234,0.92 [0.73-1.15],0.4578269862742451
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,18771,235,1.00 [0.80-1.24],0.9753499595136124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,18741,238,0.99 [0.72-1.36],0.9531437608140276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,15656,189,0.97 [0.75-1.25],0.8181389637642278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,18640,235,0.98 [0.88-1.09],0.6686604165501939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,18200,231,1.24 [0.93-1.67],0.1420923265750103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,16110,194,1.19 [0.75-1.89],0.4642352179924169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",16090,198,1.02 [0.93-1.12],0.6787989996000718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,18507,234,0.97 [0.87-1.07],0.5386167638866811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,16083,195,0.89 [0.57-1.39],0.6029169032786755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,15614,190,0.74 [0.59-0.94],0.0117743787343337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,18286,230,1.05 [0.91-1.21],0.5068624753528236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,15789,194,1.02 [0.84-1.24],0.851042212431679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,15656,189,1.42 [0.86-2.33],0.1690509624232666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15656,189,0.95 [0.65-1.39],0.7890584738415269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,18178,232,0.89 [0.75-1.05],0.1620582293030449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,18267,228,1.24 [0.96-1.59],0.0973108741285655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,15614,190,1.01 [0.80-1.28],0.9076260052041664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,16090,198,1.01 [0.87-1.19],0.8662487265270226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,16110,194,1.08 [0.73-1.59],0.7109147644018257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,15656,189,0.94 [0.63-1.41],0.763969532561285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,15865,196,0.85 [0.66-1.10],0.2225566537030734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,16083,195,0.90 [0.74-1.10],0.3094421776901922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,16090,198,1.07 [0.88-1.30],0.4961627144755746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,16083,195,0.97 [0.75-1.25],0.803356552951014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,15691,190,1.01 [0.96-1.07],0.5925368624579666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,15580,187,0.49 [0.27-0.89],0.0189791561257527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,15653,191,0.98 [0.84-1.13],0.7532262400679932
